Psychiatric comorbidities in ADHD
Author: Ulrich Brennecke
Review 10/2024: Dipl.-Psych. Waldemar Zdero
In persons with ADHD, the following psychiatric disorders often occur in addition (comorbid), sorted in descending order of frequency with ADHD (in % of people with ADHD) compared to the frequency in non-affected persons.
Adults with the highest 10% of ADHD symptom severity according to ADHD-E were 6.99 times more likely to experience psychological distress than non-affected adults.1
One study found 51.8% of people with ADHD had one or more comorbid mental illnesses.2
Another study in Japan in 2019 found comorbid ASD in 54.4% of children and adolescents with ADHD and affective disorders (depression, etc.) in 60.9% of adults.3
The percentages in the headings indicate the frequency of comorbidity in ADHD. Example: 70 to 80 % of children with ADHD suffer from sleep disorders, compared to 35 to 40 % of children without ADHD.
- 1. Sleep disorders
- 2. Motor clumsiness
- 3. Affective disorders (depression / dysphoria / dysthymia / mania) - 30 to 61 % (compared to 4.7 to 8.9 % = + 550 %)
- 4. Aggressive behavior - over 50%
- 5. Severe behavioral disorder (disruptive behavior disorders) - 30 to 50 %
- 6. Anxiety disorders - up to 47 % (compared to 19.5 %)
- 7. Substance abuse and addiction - up to 45
- 8. Restless legs (RLS, akathisia) - 11 to 44 % (vs. 2.6 to 15.3 %)
- 9. Premenstrual dysphoric disorder (PMDD) - 31.4 % (vs. 9.8 %)
- 10. Developmental disorder - 24.7 %
- 11. Autism Spectrum Disorders (ASD) - 3.6% to 85% (compared to 0.40% for girls to 1.85% for boys)
- 12. Impulse control disorder, impulse control disorder - 19.6 % (vs. 6.1 %)
- 13. Adjustment disorders - 18.9 % (compared to 3 %)
- 14. Learning disorders - up to 92
- 15. Partial performance disorders - up to 40
- 16. Mental disability - 13 %
- 17. Bipolar Disorders - 4.5 to 35.5 % (compared to 0.2 to 3.6 %)
- 18. Eating disorders - Loss of Control Eating Syndrome (LOC-ES) - 7.5 to 11.4 % (vs. 1.4 %)
- 19. Personality disorders (in adults) - 11.5 % to 33.2 % (compared to 0.9 % to 1.4 %)
- 19.1. Antisocial PS - 18 % (compared to 2 to 3.5 %)
- 19.2. Borderline PS / Emotionally unstable PS - 18 to 33 % (vs. 1 to 5 %)
- 19.3. Anxious PS - 10.6 % (vs. 2.1 %)
- 19.4. Self-insecure PS
- 19.5. Compulsive PS - 19.3 (vs. 7.8 %)
- 19.6. Combined PS
- 19.7. Paranoid PS - 14.8 % (compared to 4.1 %)
- 19.8. Dependent PS - 3.1 % (vs. 0.4 %)
- 19.9. Narcissistic PS
- 19.10. Histrionic PS (10.7 % compared to 1.6 %)
- 19.11. Schizotypal PS - 22.4 % (vs. 3.5 %)
- 19.12. Schizoid PS - 9.2 % (compared to 2.9 %)
- 20. Behavioral disorders / social disorders (aggression, antisocial behavior, oppositional defiant behavior) - 1.5 to 20.2 % (compared to 4.3 %)
- 21. Epilepsy - 3.4 % (compared to 0.5 to 1 %)
- 22. Schizophrenia - 3.4 % (compared to 0.8 %)
- 23. Obsessive-compulsive disorder - 1.9 to 2.4 %
- 24. Intellectual disability - 1.4 %
- 25. Post-traumatic stress disorder (PTSD) - 11.9% to 28% (compared to 3.3% to 6%)
- 26. Tic disorders 30 % (compared to 5 %)
- 27. Migraine
- 28. Obesity
- 29. Socialization disorder
- 30. Disorder of sexual development
- 31. Narcolepsy
- 32. Messi syndrome / Hoarding
- 33. Attachment disorders
- 34. Enuresis (enuresis)
- 35. Encopresis (defecation)
- 36. Suicidal tendencies - 2.4 to 6.7-fold
- 37. Fibromyalgia - 4-fold
- 38. Chew nails
- 39. Mental disorders in relatives of people with ADHD - 6.8-fold
- 40. Psychoses - 8.8 % (compared to 3 %)
- 41. Dopamine transporter deficiency syndrome (DTDS)
- 42. Stuttering
1. Sleep disorders
1.1. Sleep disorders in children with ADHD - 70 to 80 % (compared to 35 to 40 % = + 100 %)
70 - 80 %4; 73.3 % (28.5 % mild plus 44.8 % moderate and severe),56 twice as common as in children not affected by the disease78
For the treatment of sleep disorders ⇒ Sleep problems with ADHD.
A meta-analysis found that around 33% of people with narcolepsy also have ADHD.9
Narcolepsy is associated with a reduced level of dopamine in the cerebrospinal fluid. This is consistent with the dopamine deficiency found in ADHD. In dogs with narcolepsy, on the other hand, increased dopamine levels were found in the amygdala and increased noradrenaline levels in the oral pontine reticular nucleus. Nevertheless, the dogs respond to stimulants that increase dopamine and noradrenaline.10
Kooij sees sleep disorders (difficulty falling asleep or sleeping through the night) in 43% of people with ADHD.11
1.2. Sleep disorders in adults with ADHD
Sleep problems that last longer than a month are called sleep disorders.
- In adult people with ADHD: 11.3%12 to 29%13
- For non-affected persons: 2.3 %12
= 5 to 12 times the risk
Of the 670 adult persons with ADHD (with a medical diagnosis) who took the ADxS.org online symptom test, 69% reported sleep disorders, compared to 39% of the 159 people with ADHD who said they were certainly not affected (as of March 1, 2022).
A meta-analysis found that around 33% of all people with narcolepsy also had ADHD.9
1.3. Consequences of sleep disorders (sleep disorders: children 47.1 %; adults: 0.6 to 7.8 %)
The annual prevalence of sleep disorders in Germany in 2008 was 0.6 % (15 to 19 years) to 6.6 % (60 years and over) for men and 0.8 % (15 to 19 years) to 7.8 % (60 years and over) for women.14
Sleep problems with ADHD are extremely common:
- 70 - 80 % of people with ADHD suffer from sleep problems
- 20 - 30 % of people with ADHD suffer from sleep problems
A Chinese study of 23,791 schoolchildren found that 68.7% of children with ADHD had poor sleep quality, compared to 47.1% of children without ADHD15
See also: ⇒ ADHD - comorbidity, there on sleep problems
When it comes to sleep problems and ADHD, it is difficult to separate cause and effect. ADHD very often causes sleep disorders and sleep disorders often cause ADHD-like symptoms.
In the case of an ADHD diagnosis, comorbid sleep disorders should always be treated with special priority. In addition, when taking medication for sleep problems, their possible negative effect on ADHD symptoms must be taken into account, just as medication for ADHD must be checked to ensure that it does not exacerbate sleep problems. More on the treatment of sleep problems with ADHD: ⇒ Treatment of sleep problems with ADHD
- Vigilance disorders with impaired sleep-wake regulation1617
- Consequences of sleep apnea syndrome18
“Obstructive sleep apnoea syndrome (OSAS) is the most common sleep-related breathing disorder. The prevalence is around 4% in men and around 2% in women.
Obstructive sleep apnea (OSA) is even more common and reaches strikingly high figures, particularly when subgroups are considered. For example, there is a prevalence of around 36% in patients with diabetes mellitus or arterial hypertension, a prevalence of 50% in obese patients and a prevalence of 83% in patients with refractory arterial hypertension. It is estimated that 80 % of male and 90 % of female patients with sleep apnoea syndrome are undiagnosed and therefore untreated.”19
Breathing interruptions in children’s sleep can trigger cognitive stress, causing symptoms that resemble ADHD.20 - Chronic lack of sleep16
- Disorders of the dream sleep phases occur within a few days:
Common symptoms of sleep problems and ADHD:24
- Motor hyperactivity, physical restlessness
- Concentration problems
- Attention problems
ADHD symptoms that are atypical of sleep problems:
- Inner restlessness (typical in atypical depression, less so in melancholic depression)
- Impulsiveness
- High flow of speech (logorrhea, polyphrasia)
- Chasing thoughts, circling thoughts
- Rapid mood swings
- Dysphoria with inactivity
Symptoms of sleep problems that are atypical for ADHD:
- Drowsiness
- (Day) tiredness
2. Motor clumsiness
Source6
2.1. Developmental motor coordination disorder - 47 %
Developmental coordination disorder (DCD) occurs in 47% of people with ADHD.2526
A combination of ADHD and DCD usually represents a more severe phenotype. Despite some shared neuronal features, ADHD and DCD appear to have a separate etiology.26
Diagnostic criteria according to DSM 5:
- The learning and execution of coordinated motor skills (if the opportunity to learn the skills is given) is below the level expected for the age.
- The motor difficulties significantly impair the activities of daily life and have an impact on school performance, pre-professional and professional activities as well as leisure and play.
- The beginning is in the early development phase.
- A doctor cannot better explain motor difficulties by intellectual delay, visual impairment or other neurological conditions that affect movement.
The delay is usually in the acquisition of motor skills. Motor milestones are often not delayed.
2.2. Gross motorist
Frequent accidents, bumping into things, bruises. See also under Symptoms of ADHD.
2.3. Impaired fine motor skills, poor handwriting - 60 %
Up to 60% of people with ADHD suffer from impaired fine motor skills, such as poor handwriting.27
3. Affective disorders (depression / dysphoria / dysthymia / mania) - 30 to 61 % (compared to 4.7 to 8.9 % = + 550 %)
Dysphoria with inactivity is an original ADHD symptom and not a symptom of depression. Antidepressant treatment of dysphoria with inactivity would be malpractice.
⇒ Depression and dysphoria in ADHD
Of 70 adults with ADHD, 60.7% had had an affective disorder in their lifetime, compared to 25.7% of those not affected 28
3.1. Depression
Depression found
- according to a large Swedish cohort study in 42.28% (men: 35.60%; women: 40.27%) of adult people with ADHD compared to 4.69% (men: 3.55%; women: 5.87%) of those without.29
- according to another cohort study at 29.9 % (over the entire age range) and 55.7 % compared to 24.3 % in a small study of adults28
30 - a Norwegian cohort study found major depression in 24.5 % (men: 20.3 % women: 28.8 %) of adult people with ADHD compared to 5.8 % (men: 4 %; women: 7.6 %) of those not affected.31
- In children with people with ADHD:
- For children not affected: 8.9 %33 to 14 % 32
= 4 times the risk - Mood swings (15 - 75 %)35
- Depressive disorders6
- A simple survey by www.adhs-chaoten.net, in which 73 people with ADHD took part, revealed that a majority suffer from seasonal fall-winter depression.36 This is quite regularly the result of a vitamin D3 deficiency.
⇒ Vitamin D3 - In adult people with ADHD: 61.8 %12;
Depression (40 to 60 %)37; 25 %13 - Severe depression (MDD
- Depression (adults with ADHD overall: 21.4 %; women 32.1 %, men 19.8 %; ADHD-I 22.3 %, ADHD-C 17.6 %, ADHD-HI 32.5 %)40
- The population prevalence of major depression is 7.8%. People with ADHD have a prevalence of 18.6%, which is 2.4 times higher.41
- Adults with the highest 10% of ADHD symptom severity according to ADHD-E are 6.68 times more likely to experience depression than non-affected adults.1
-
A meta-analysis found depression in people with ADHD and those without:42
- in the total population at
- 8.6 % to 55 % of persons with ADHD compared to 1.2 % to 12.5 % of people without ADHD
- in clinical cases with
- 15.4 % to 39.7 % of persons with ADHD compared to 5.8 % to 39.6 % of people without ADHD
- in the total population at
-
Predictors of comorbid depressive symptoms in adults with ADHD are
- female gender
- Women with ADHD had a 3.69-fold risk of depression. Women with ADHD who used hormonal contraception (“pill”) had a 5.19-fold risk of depression.43
- Cyclothymic affective temperament and coping strategies with little positive attitude44
- emotional dysregulation and dysthymic temperament45
- female gender
3.2. Dysthymia
Dysthymia was found in:
- Adults with ADHD overall: 7.3 %; women 9.4 %, men 5.4 %; ADHD-I 6.3 %, ADHD-C 7.6 %, ADHD-HI 15 %)40
- In 6.1% of adult persons with ADHD compared to 3.4% of people without ADHD at least once in their lives39
- The population prevalence of dysthymia is 1.9%. People with ADHD have a prevalence of 12.8%, which is 6.7 times higher.41
- Dysthymia 5.7 % compared to 1.4 %28
3.3. Bipolar Disorders
Bipolar Disorders (“manic/depressive”):
- at 6 %13; (adults with ADHD overall: 6.4 %; women 8.3 %, men 4.7 %; ADHD-I 5.1 %, ADHD-C 8.0 %, ADHD-HI 10.0 %)40 to 4.7 % (over the entire age range)30
- In 33.5% of adult persons with ADHD compared to 6.2% of people without ADHD at least once in their lives39
- The population prevalence of Bipolar Disorder is 3.1 %. People with ADHD have a prevalence of 19.4 %, which is 6.3 times higher.41
-
In adult psychiatric clinical patients with ADHD: 92.2 %46
-
For those not affected: 14.3 %12
-
Mania 0.15 % (for ADHD over the entire age range)2
-
57 to 86% of children and adolescents with Bipolar Disorder also have ADHD47
4. Aggressive behavior - over 50%
Slightly more than 50 %48
Aggressive behavior is not an original symptom of ADHD-HI. Aggressiveness can be an expression of stress, but not everyone reacts to stress with aggression, nor does everyone externalize stress.
One of the arguments in favor of pure comorbidity is that non-ADHD-specific drugs such as risperidone only reduce aggressiveness but not ADHD symptoms, while MPH (methylphenidate) can alleviate the symptoms of ADHD and ODD in equal measure.49
See also ⇒ Neurophysiological correlates of aggression
5. Severe behavioral disorder (disruptive behavior disorders) - 30 to 50 %
Frequency of comorbidity in children with ADHD:
- 50 %50
- 31% in Iran for children between the ages of 6 and 1851
- Among people with ADHD, 30 to 50 % have comorbid ODD or CD.52
Newer definition models of externalizing aggressive disorders are
5.1. Deficient emotional self-regulation (DESR) - 44 to 55 %
DESR is described as
- Self-regulation deficits of physiological arousal caused by strong emotions
- Difficulty inhibiting inappropriate behavior in response to positive or negative emotions
- Problems with refocusing attention when emotions are strong
- Disorganization of behavioral coordination in response to emotional activation
- DESR is distinct from the persistent and severe aggressive irritability that is common in pediatric bipolar Disorder (which is rare).54 The abnormal moods of bipolar Disorder are not due to poor self-control and include other DSM-IV mood criteria.
DESR is not associated with an increased risk of bipolar Disorder.55
In studies, DESR was found in 44%55 to 55%56 of persons with ADHD, compared to only 2% of people without ADHD.55
DESR is diagnosed if the person with ADHD scores between 180 and 210 points on the 3 scales of anxiety/depression (intense emotions), aggression and attention (impulsivity) of the Child Behavioral Check List (CBCL) (on average between 60 and 70 per scale). Scores above 210 points are no longer referred to as DESR, but as more severe forms of affective disorders (mood and behavioral dysregulation disorders). Due to the defined diagnostic criteria of DESR, which cannot be achieved without a high score on the aggression scale, the diagnosis of DESR is likely to be limited to the ADHD-HI subtype, which is phenotypically more likely to react to perceived stress with aggression
The CBCL scale for aggressive behavior:57- Argues or disagrees a lot
- Specifies, cuts to
- Is crude or mean to others, intimidates them
- Requires a lot of attention
- Breaks his own things
- Breaks things that belong to parents, siblings or others
- Does not obey at home
- Does not obey at school
- Is easily jealous
- Easily gets into fights, arguments
- Physically attacks others
- Screams a lot
- Likes to produce or clown around
- Is stubborn, grumpy or irritable, is easily annoyed by others
- Shows sudden changes in mood and emotion
- Talks too much
- Likes to tease others
- Has outbursts of anger or a hot temper
- Threatens, bullies or intimidates others
- Is unusually loud
According to our assessment, all question topics are primarily aimed at the ADHD-HI subtype (with hyperactivity), while only question topics 7, 8, 9, 14 and 15 also fit the ADHD-I subtype, but do not specifically ask about possible symptoms of inwardly directed emotional intensity. In the predominantly inattentive subtype (ADHD-I), barely any externalizing symptoms such as aggression or oppositional defiant behaviour occur.58 According to our understanding, the ADHD-I subtype internalizes perceived stress and does not primarily react aggressively.
DESR can therefore only occur in people with ADHD-HI and ADHD-C, not ADHD-I.
We assume that people with ADHD-I also suffer from emotional dysregulation, which just does not or rarely manifests itself as aggression. This perception was confirmed by an ADHD therapist in a personal interview.
Consequently, significantly more than 44 to 55% of all people with ADHD are likely to suffer from emotional dysregulation, although the forms of expression can vary greatly
Here, too, studies would be desirable that take into account the subtypes and the phenotypic expression of intense emotions (ADHD-HI: externalization / ADHD-I: internalization).
5.2. Oppositional Defiant Disorder (ODD) - 26 to 53 % (compared to 3.9 % = + 560 % to + 1,260 %)
-
In children and adolescents with ADHD-C: 53 %59
-
Among people with ADHD, 30 to 50 % have comorbid ODD or CD.52
-
Biedermann quotes an ODD prevalence of 60% in children with ADHD.60 We consider this to be a translation. In our opinion, this could at best apply when considering only boys with severe ADHD-HI. In addition, the ODD prevalence of boys is given as 55 % and of girls as 30 %, which does not match the overall prevalence. For adults, Biederman cites a prevalence of 30% for the entirety of social behavior disorders in ADHD60
-
ODD 26.1% in Iran among children between 6 and 18 years of age.51
-
For those not affected: 3.9%12
= 10 times the risk -
ODD refers primarily to people with ADHD-HI (with hyperactivity) rather than ADHD-I (without hyperactivity), as hyperactivity is an outgrowth of an externalizing stress response pattern, whereas ADHD-I is an outgrowth of an inwardly directed stress (playing dead, escaping). ⇒ The subtypes of ADHD: ADHD-HI, ADHD-I, SCT and others
-
We understand ODD (Oppositonal Defiant Disorder) as a pure comorbidity to ADHD, i.e. not as ADHD symptoms.
- Steinhausen describes disorders of social behavior on the one hand as the most common comorbidity of ADHD,61 describes the comorbidity on the other hand on page 174 as a subtype of ADHD.
- Apart from the fact that sleep disorders are likely to be significantly more common, we do not consider ODD to be a subtype due to the delimitability of the genetic basis.
- A specific polymorphism of the MAO-A gene is cited as a genetic contributory cause of both social behavior disorders and ADHD (in each case as one of several interacting specific genes). However, this gene polymorphism seems to play a much greater role with regard to social behavior disorders, as it is mentioned much more frequently there and ADHD can also manifest itself without the involvement of this gene (through the interaction of other genes). In the case of ADHD, the MAO-A gene is always mentioned in a subset of people with ADHD who also suffer from behavioral disorders.
- A further argument in favor of pure comorbidity is that non-specific ADHD medications such as risperidone only reduce aggressiveness but not ADHD symptoms, while MPH (methylphenidate) can alleviate the symptoms of ADHD and ODD equally.49
-
ODD does not correlate with any of the symptom circuits of the dual / triple pathway model, so at least in this respect it has a different neurological basis.62
Symptoms Oppositional defiant disorder (ODD):
- Frequent and persistent defiance or disobedience towards authority figures
- Quarrelsome and easily irritated or annoyed
- Deliberate attempts to annoy others or behave vindictively
- Difficulty following rules and displaying a pattern of negative, hostile and defiant behavior
5.3. Disorders of social behavior / Conduct Disorder (CD)
Source6
- Persons with Disorder of Social Behavior have 21 times the risk (compared to people with ADHD) of also suffering from ADHD.63
- Disorders of social behavior and aggression disorders have their own genetic disposition in a specific polymorphism of the MAO-A gene. ⇒ How ADHD develops: genes or genes + environment
- Biedermann cites a CD prevalence of 16% in children with ADHD (boys 18%, girls 8%)60
The prevalence of conduct disorder was determined by an Iranian study:64
- 0.58 % for children aged 6 to 9 years
- 0.57 % for adolescents aged 10 to 14 years
- 1.22 % for young people aged 15 to 18
32% also met the criteria for ADHD, 55% the criteria for ODD.
Symptoms of conduct disorder (CD):
- Aggressive or violent behavior
- Frequent physical altercations
- Harm to humans or animals
- Bullying or cruelty
- Antisocial behavior
- Frequent disregard for the rights of others
- Recurring and persistent patterns of difficulties in accepting norms
- Destruction of property
- Participation in thefts
- Fraudulent behavior
- Lies
- Lack of remorse or feelings of guilt for one’s own actions
- Lack of empathy
6. Anxiety disorders - up to 47 % (compared to 19.5 %)
The population prevalence of anxiety disorders is 19.5%.65 People with ADHD have a prevalence of 47.1%, which is around 2.4 times higher.41 Generalized anxiety disorder (a form of anxiety disorder) affects up to 5 % of children and adolescents and between 3 and 6 % of adults.66
There was no genetic overlap between ADHD and anxiety disorders. Genes that correlated with high intelligence showed a protective factor against ADHD, but not against anxiety disorders.67
6.1. Anxiety disorders in children - 25 to 38 % (compared to 7 to 10 % = up to + 400 %)
- 37.9% in Iran for children between 6 and 18 years of age.51
- 37.34 % (compared to 7.42 % for people not affected by ADHD) = 5-fold risk of depression or anxiety disorder34
- 37 % over the entire age range30
- 34 %68,
- 25 %6935 ,
- Increased (without % indication)70
- For non-affected persons 7.42 %34 to around 10 %71
= 3 to 5 times the risk - Anxiety disorders and ADHD seem to reinforce each other. Treating anxiety or AD(HS also reduces the symptoms of the other Disorder.72
- Generalized anxiety disorder tripled and a half the risk of ADHD, while ADHD quadrupled the risk of generalized anxiety disorder.73
- 40 to 85% of children with an anxiety disorder also had ADHD74
6.2. Anxiety disorders in adults - 44 % (compared to 4.9 %)
An anxiety disorder was found in 44.65% (men: 37.02%; women: 55.74%) of adults with ADHD compared to 4.89% (men: 3.64%; women: 6.19%) of people without ADHD, according to a large Swedish cohort study.29 A Norwegian register study found a prevalence of 22.2 % (men: 18.2 %; women: 26.3 %) of adult people with ADHD compared to 5 % (men: 3.3 %; women: 6.7 %) of those not affected.31
Other sources cite a prevalence of 42 % or 20 to 60 % in adults with ADHD37; 19 % anxiety disorders and 15.5 % phobic disorders13
In adult psychiatric clinical patients with ADHD: 25%69 to 28.6%46
- Of 70 adults with ADHD, 34.3% had an anxiety disorder in their lifetime, compared to 25.7% of the 70 unaffected28
Anxiety disorders and ADHD seem to reinforce each other. Treating anxiety or AD(HS also reduces the symptoms of the other Disorder.72
A meta-analysis found an anxiety disorder:42
- in the total population at
- 4.3 % to 47.1 % of persons with ADHD compared to 0.5 % to 9.5 % of people without ADHD
- in clinical cases with
- 3.9 % to 84 % of persons with ADHD compared to 5.4 % to 40 % of people without ADHD
6.2.1. Generalized anxiety disorder - 5.9 to 25 % (vs. 2 %)
- The population prevalence of generalized anxiety disorder is 2.6%. People with ADHD have a prevalence of 8%, which is around 3 times higher.41
- Total adults 2.6 %; women 2.9 %, men 3.7 %; ADHD-I 1.2 %, ADHD-C 5.0 %, ADHD-HI 12.5 %40
- In adult people with ADHD:
- For non-affected persons: 2 %38
= 3 to 12 times the risk
Of 70 adults with ADHD, 2.9% had a generalized anxiety disorder in their lifetime, compared to 1.4% of the 70 unaffected28
6.2.2. Social phobia - 5 to 29.3 % (compared to 3.5 to 10 %)
Adults with ADHD overall: 3.5 %; women 2.5 %, men 4.4 %; ADHD-I 3.3 %, ADHD-C 3.0 %, ADHD-HI 7.5 %40
Of 70 adults with ADHD, 18.6% had social phobia in their lifetime, compared to 10% of the 70 unaffected28
Social anxiety disorder was found in 22.8% of adult persons with ADHD compared to 6.6% of non-affected people at least once in their lifetime.39
The population prevalence of social phobia is 7.8%. People with ADHD have a prevalence of 29.3%, which is almost 3.8 times higher.41
6.2.3. Panic disorder - 1.9 to 4.3 % (compared to 2.9 %)
Adults with ADHD overall: 1.9 %; women 2.9 %, men 2.4 %; ADHD-I 2.1 %, ADHD-C 2.5 %, ADHD-HI 7.5 %40
Of 70 adults with ADHD, 4.3% had a panic disorder in their lifetime, compared to 2.9% of the 70 unaffected28
- At least once in the lifetime of 22% of adult persons with ADHD compared to 7% of people without ADHD39
- The population prevalence of panic disorder is 3.1%. People with ADHD have a prevalence of 8.9%, which is almost 3 times higher.41
6.2.4. Specific phobias
- Specific phobias were found in 35.8% of adult persons with ADHD compared to 14.6% of people without ADHD at least once in their lives39
- The population prevalence of specific phobias is 9.5%. People with ADHD have a prevalence of 22.7%, which is almost 2.4 times higher.41
- The population prevalence of agoraphobia is 0.7%. People with ADHD have a prevalence of 4.0 %, which is around 5.7 times higher.41
7. Substance abuse and addiction - up to 45
A meta-analysis found addictive disorders:75
- in the total population at
- 2.3 % to 41.2 % of persons with ADHD compared to 0 % to 16.6 % of people without ADHD
- in clinical cases with
- 10 % to 82.9 % of persons with ADHD compared to 2 % to 72.2 % of people without ADHD
Among patients of addiction centers, ADHD serial studies found 21 to 23% of people with ADHD76, which corresponds to 4.6 to 9.2 times the adult ADHD population prevalence of 2.5 to 5%. One study found 45% of people with ADHD77, which corresponds to 10 to 20 times this figure
7.1. Substance-related addictions / substance abuse
Of n = 873 patients in a psychiatric emergency department in an emerging urban county in North Carolina (USA) with ICD10 diagnoses of anxiety, depression, schizophrenia, ADHD, bipolar disorder, alcohol abuse, or schizoaffective disorder showed:78
- 58% of patients with a psychiatric history have a positive urine drug test
- ADHD (n = 135)
- 34.7 % alcohol
- 20.2 % THC
- 15.3 % Cocaine
- 14.9 % Paracetamol
- 12.9 % Benzodiazepines
- 12.1 % Opiates
- 8.1 % Amphetamine drugs
- 1.6 % barbiturates
- Depression (n = 225)
- 40.8 % Paracetamol
- 25.6 % THC
- 20.9 % alcohol
- 15.0 % Opiates
- 13.7 % Benzodiazepines
- 12.6 % Cocaine
- 7.4 % Amphetamine drugs
- 2.1 % barbiturates
- States of anxiety
- 30.8 % THC
- 10.3 % alcohol
- 5.1 % Opiates
- 5.1 % Cocaine
- 4.7 % paracetamol
- bipolar disorders
- 29.4 % THC
- 27.3 % alcohol
- 16.9 % Opiates
- 13.0 % Cocaine
- 10.4 % Benzodiazepines
- 9.2 % Paracetamol
- 8.2 % Amphetamine drugs
- Schizoaffective Disorder (n = 245)
- 26.1 % THC
- 25.6 % alcohol
- 24.4 % Paracetamol
- 20.8 % Cocaine
- 12.1 % Benzodiazepines
- 8.7 % Opiates
- 5.1 % amphetamine drugs
- 2.5 % barbiturates
- Schizophrenia (n = 45)
- 32.6 % THC
- 14.4 % alcohol
- 10.9 % Cocaine
- 5.5 % paracetamol
- 8.7 % Benzodiazepines
- 2.2 % opiates
Overall, there was no significant correlation between the psychiatric diagnosis and positive drug screening.78
7.1.1. Substance abuse - 21.9% to 35% (compared to 2.9% to 3.6%)
According to a large Swedish cohort study, substance misuse (SUD) was found in 35.12% (men: 39.44%; women: 30.88%) of adult people with ADHD compared to 3.61% (men: 4.40%; women: 2.79%) of non-affected people.29
A large Norwegian cohort study found substance misuse in 21.9% (men: 27.5% women: 16.2%) of adult people with ADHD compared to 2.9% (men: 3.6%; women: 2.1%) of those without.79
Among adult SUD patients in three drug rehabilitation centers in urban Malaysia, ADHD prevalence was 47.2%. SUD affected persons with ADHD were less likely to have medical comorbidities (84.9% vs. 93.3%), more likely to have a history of incarceration (80.8% vs. 65.6%) and more likely to have a first incarceration before the age of 18 years (24.6% vs. 16.8%) compared to SUD affected persons.80
Substance abuse is a common comorbidity of ADHD.6 One possible connection could be that dopamine deficiency leads to increased expression of CB1 cannabinoid receptors.818283 THC binds to CB1 receptors.
Of 70 adults with ADHD, 17.1% had experienced substance misuse in their lifetime, compared to 2.9% of those without28
People with ADHD showed an ADHD prevalence of 21% (meta-analysis).84
Among 153 addicts (98.7% males) at a clinic in India, 33% were found to have ADHD. The prevalence of ADHD was different for certain addictions:85
- 47.6 % of people with cannabis addiction
- 38.8 % of people who use tobacco/smoke
- 33% of people with cocaine addiction and
- 21.5 % of people with alcohol dependence.
- The prevalence of ADHD among opioid addicts was around 50%. ADHD symptoms, especially impulsivity, increase the risk of opioid addiction. 86
- For people with ADHD, substance abuse begins on average 3 years earlier87
- Appropriate medication (especially methylphenidate) reduces the likelihood of addiction or substance abuse in ADHD.
- People with ADHD with comorbid cocaine addiction showed a significant reduction in addictive behavior when treated with stimulants, corresponding to a decrease in ADHD symptoms.88
A small Norwegian cohort study found no association between ADHD and alcohol or drug abuse,89 as well as an earlier study,90 which found increased alcohol and drug abuse in people with ADHD only in the presence of additional externalizing disorders.
However, these studies clearly contradict the vast majority of specialist literature, which reports a significant risk increase in ADHD.
7.1.2. Smoking - 40 to 45 % (compared to 22 to 25 %)
- In adult persons with ADHD: 40%91 to 42%9293 to 44.8%39
- Compared to 22.6%39 to 26% of those not affected (2005),94 therefore a 61% increased risk (regardless of medication).
- In adult psychiatric clinical patients with ADHD are dependent on nicotine
- 51 %46
- For those not affected:
- ADHD medication, nicotine (smoking) and zinc block the dopamine transporters (DAT) (which are elevated in ADHD) and thus reduce their overactivity97
7.1.3. Alcohol dependence (30 to 39 % compared to 5 to 15 %) / alcohol abuse
The German guidelines now stipulate ADHD testing as a standard procedure for alcohol addiction.
Alcohol dependence is drastically increased with ADHD98
- In adult persons with ADHD between 30 %38, 25 to 44 %96 and 38.9 %39
- In adult psychiatric inpatients with ADHD, one study found alcohol dependence in 4.1%.46
- For those not affected: 5%38 to 14.6%39
= 6 to 8 times the risk
Conversely, among n = 153 alcoholics, 43% were found to have childhood ADHD and 22% were found to have persistent ADHD.99 Another study found an ADHD diagnosis in 19% of 100 adult alcoholics in India.100 - Alcohol / substance abuse: Adults with ADHD overall: 1.6 %; women 1.1 %, men 2.0 %; ADHD-I 0.9 %, ADHD-C 2.5 %, ADHD-HI 2.5 %40 to 18.1 % / 22.6 %39 compared to 19.3 % in non-affected persons39
- Of 70 adults with ADHD, 8.6% had an alcohol dependency in their lifetime, compared to 2.9% of those without28
- A small Norwegian cohort study found no association between ADHD and alcohol or drug abuse,89 as well as an earlier study,101 which found increased alcohol and drug abuse in people with ADHD only in the presence of additional externalizing disorders.
For alcohol dependence, 6 parameters predicted the presence of comorbid ADHD with an AUC of 0.926:.98
- reduced self-control
- increased novelty sseking
- Self-transcendence
- Damage prevention
- Craving
- early first consumption of alcohol
Self-steering and novelty seeking together achieved an accuracy of 85%.98
7.1.4. Substance-related addictions in general - 7.8 %
- In adult persons with ADHD: 7.8 %12, 20 %38 to 50 to 60 %102103
- For those not affected: 1.9 %12 to 5 %38103
= 4 to 12 times the risk - According to another source, the lifetime prevalence of psychoactive substance use in people with ADHD is 52%, compared with 24% in people without the disorder.104
- Of 70 adults with ADHD, 11.4% had a substance dependence in their lifetime, compared to 0% of the 70 unaffected28
7.1.5. Drug addiction
- The population prevalence of drug addiction is 0.6%. People with ADHD have a prevalence of 4.4 %, which is around 7.3 times higher.41
- Among adult psychiatric clinical patients with ADHD, 7.1% have comorbid drug dependence.46
- Drug addicts are 4 to 5 times more likely to have ADHD105
- 15.5%106 to 25% of all addicts have ADHD107
- ADHD was found in 11.2% of all adult addiction patients who used intravenous opiods or intravenous/intranasal benzodiazepines. The ADHD rate was higher among women (15.3 %) than among men (10.3 %).108
- With ADHD, the risk of substance dependence (addiction) is 2 to 3 times higher than for those not affected.109
- With ADHD, the risk of nicotine dependence is up to 9 times higher than in those not affected.109
- Persons with ADHD are about as likely to be addicted as relatives who are not affected by ADHD.
- According to one study, 12% of cocaine users had ADHD in childhood and 10% still had it as adults.110
7.2. Behavioral addiction / gambling 5.3 % (vs. 2.4 %)
People with ADHD have more than double the risk of developing a gambling addiction (5.3% compared to 2.4%). Problem gambling behavior is 4 times more common among persons with ADHD (2.4%) than among people without ADHD (0.6%).111
Another study found gambling addiction in 1.54% of adult persons with ADHD compared to 0.39% of non-affected people at least once in their lifetime.39
A study of n = 97 gambling addicts found an ADHD rate of 26.0 % and an ASD rate of 29.8 %.112
One study found that gene variants that correlate with substance use can causally increase the risk of ADHD.113
7.3. Substance abuse (illegal drugs: 10 %, nicotine: 16.6 to 25.5 %)
Among adults with ADHD, the prevalence of substance abuse is 33.5%.114 The risk of substance abuse among adults with ADHD in the USA is 1.7 to 7.9 times higher.115
The prevalence of substance abuse among German adults in 2019 was (12-month prevalence and lifetime prevalence)116
Cannabis: 7.1 % / 28.3 %
Cocaine / crack: 1.1 % / 4.1 %
Ecstasy: 1.1 % / 3.9 %
Amphetamines: 1,2 % / 3,8 %
Methamphetamine / crystal meth: 0.2 % / 0.8 %
Smoking (at least 20 cigarettes/day), adults:117
- Men: 25.5 %
- Women 16.6 %
Alcohol:118
- Risky consumption within 12 months
- Men 15.6 %
- Women 12.8 %
One study found an ADHD prevalence of 20.5% among patients hospitalized for alcohol dependence.119
If aggressive and oppositional defiant behavior and low self-esteem are present in addition to ADHD, the probability of substance abuse is significantly increased, while no more frequent substance abuse was found in adolescent people with ADHD without these additional symptoms.120121
In our opinion, substance abuse is much more likely to be a consequence of ADHD than the cause of a full ADHD symptom picture. In rarer cases, it is comorbid. Treatment with stimulants very often eliminates the addictive tendency in ADHD. Modern dosage forms of stimulant medications are barely suitable for abuse as a drug (e.g. Vyvanse: prodrug of amphetamine bound to lysine, which is only very slowly converted to the active ingredient in the intestine).
In the Continuous Performance Test, people with ADHD showed more responses to correct timing compared to those with substance abuse.122
7.4. Addiction / dependency (alcohol: 5%, gambling: 0.31%)
Prevalence: Present in 24.9% of adults with people with ADHD.123
Alcohol:118
- Dependence
- Men 4.8 %
- Women 2 %
- Abuse
- Men 4.6 %
- Women 1.5 %
In Berlin, 5.0% of respondents aged 15 to 64 met the criteria for alcohol dependence according to DSM-IV (men: 6.4%, women: 3.5%).124
In Germany, the prevalence of gambling addiction is 0.31% and the prevalence of problematic gambling behavior is 0.56%.125
A study of n = 97 gambling addicts found an ADHD rate of 26.0 % and an ASD rate of 29.8 %.112
In the case of comorbidity of ADHD and addiction, there is an increased probability that ADHD is the causal cause of the addiction and not addiction the cause of ADHD. This was shown at least for smoking, cannabis and probably also alcohol.126
One study found that increased polygenic risk scores (PRS) for ADHD also increased the likelihood of addiction by 20%. There were no differences with regard to the intensity of the addiction (use, abuse, dependence) or the type of addictive substance (alcohol, cannabis, other illegal drugs). Conversely, the ADHD-PRS explained only 0.2% of the probability of addiction compared to other risk factors.127
One study showed an ADHD prevalence of 16.7% in severe addicts compared to 2.5% in the control group.128
Even more significant was the fact that 53% of severe addicts had socially disturbed behavior in childhood or adolescence (up to 15 years), as measured by the SKID-II (control subjects with 2.5%).129 An earlier Disorder of Social Behavior (OR = 35.1) compared to childhood hyperkinetic behavior (OR = 5.7) is by far the greater risk factor for severe addiction.130
This indicates to us that addiction plays a role predominantly in ADHD-HI and less in ADHD-I.
The preference for addictive substances indicates a more frequent use of cannabis products among people with (former) hyperkinetic behavior. There appears to be no significant difference for opiates, cocaine, amphetamines, sedatives and hallucinogens.131
Although a joint occurrence of hyperkinetic and socially disturbed behavior is associated with an early first use of illegal drugs, statistically only an earlier and increased use of nicotine could be proven.131
Adults with ADHD and addiction had a lower age of onset of substance use and used as an addictive substance:132
- more frequently: alcohol, cannabis, methamphetamine, tramadol
- less frequently: methylphenidate, methadone, ecstasy, morphine, hypnotics
Long-term abuse of dopaminergic drugs (cocaine, amphetamines) leads to prolonged downregulation of dopamine levels. Withdrawal symptoms then correspond to ADHD symptoms. 133 Against this background, the question arises as to whether ADHD medications (stimulants), which are known to have no intoxicating effect, could be helpful in the withdrawal of dopaminergic drugs.
People with ADHD with comorbid cocaine addiction showed a significant reduction in addictive behavior when treated with stimulants.88
Common symptoms of addiction / substance abuse and ADHD:24
- Impulsiveness
- (Inner) restlessness, motor hyperactivity
- Concentration problems
- High flow of speech (logorrhea, polyphrasia)
ADHD symptoms that are atypical for addiction / substance abuse:
- Chasing thoughts, circling thoughts
- Attention problems
- Dysphoria with inactivity
- Mood swings
Symptoms of addiction / substance abuse that are atypical for ADHD:
- Substance abuse:
- Excessive consumption of a substance, even if there are serious Consequences
- Addiction / dependence:
- Excessive consumption to the point of dependence on the drug
- Very difficult to stop
8. Restless legs (RLS, akathisia) - 11 to 44 % (vs. 2.6 to 15.3 %)
A meta-analysis found RLS in 11 to 42.9 % of children with ADHD and in 20 - 33.0 % of adults with ADHD. In the general population, RLS was found in 2.6 to 15.3%.134
A study of children with ADHD (aged 6 to 16) found RLS in 33.3%.135 Other sources speak of 44%.136 A smaller study of adults with ADHD found RLS in 20%, with comorbid RLS aggravating ADHD symptoms.137
Kooij sees RLS in 30 % to 40 % of people with ADHD.11
One study found 10% of people with ADHD had a disorder of periodic limb movements (PLMS) (more than 5/hour).138 Another study found 66% of children with ADHD had a PLM index greater than 5/hour, which is a marker for RLS, while no ADHD non-affected individuals had an elevated PLM index.139 A meta-analysis found no evidence of more frequent PLMS in ADHD.140
In adult psychiatric clinical patients with ADHD, 25.5% showed RLS46
A large cohort study found a strong correlation between restless legs and ADHD.141
ADHD is found in up to 26% of people with ADHD.136
Irrespective of ADHD, RLS occurs in around 2% of all children and adolescents, and in 0.5 to 1% in moderate to severe form. In adults, it affects 5 to 10 %. In 25% of people with ADHD, the disorder begins between the ages of 10 and 20.142 Other sources cite a prevalence of RLS of up to 8%.143
In 70% of people with ADHD, one parent is also affected.
A genetic link between RLS and ADHD has not yet been established. It is conceivable that the BTBD9 gene, which is associated with iron stores, could be involved.
69.4 % of children and adolescents with RLS have sleep disorders (compared to 39.6 % of those not affected), 80.6 % have a history of “growing pains” (compared to 63.2 % of those not affected).143
Common causes of RLS and ADHD
8.1. iron deficiency in RLS and ADHD
There is increasing evidence that iron deficiency (S-ferritin level < 12 ng/ml) underlies common pathophysiological mechanisms in patients with RLS and patients with ADHD-HI143
Iron is a cofactor for tyrosine hydroxylase, an enzyme that is essential for dopamine synthesis. ADHD and RLS both often show decreased iron levels. Lower S-ferritin levels in people with ADHD correlate with more severe ADHD-HI symptoms. Children with ADHD and RLS showed lower ferritin levels than children with ADHD without RLS.144145146 However, other studies did not find decreased S-ferritin levels in ADHD 147148
In RLS, the severity correlates more clearly with a reduced S-ferritin level.149150 particularly in children.151 It is possible that impaired transport of iron from the serum into the cerebrospinal fluid and of iron into the dopaminergic cells leads to a reduced iron concentration in the cerebrum.152 Adults with RLS show a low iron status in the cerebrum.153
Children with ADHD and a predisposition to RLS appear to represent a subgroup at particular risk for severe ADHD-HI symptoms, and iron deficiency may contribute to the severity of ADHD symptoms.144
An RC study found improved ADHD symptoms in children with ADHD and low ferritin levels when given iron (80 mg/day).154
8.2. adenosine for RLS and ADHD
Restless legs could be caused by downregulation of adenosine A1 receptors as a result of iron deficiency.155
Adenosine is closely linked to dopamine. Adenosine receptors are found throughout the brain in the vicinity of dopamine receptors and sometimes form receptor heteromers with them. Adenosine could also be involved in ADHD, although more likely via an excessive adenosine effect on adenosine A2A receptors. Adenosine inhibits dopamine, adenosine antagonists such as caffeine (coffee, cola, black tea) and theobromine (cocoa) therefore increase dopamine.
More on this in the article => Adenosine
8.3. treatment of RLS in ADHD
The problem with the comorbidity of restless legs and ADHD is that ADHD medications (although also dopaminergic) do not work against RLS and RLS medications such as L-dopa (although also dopaminergic) do not work against ADHD.156143157
Prolonged treatment with L-dopa often leads to a worsening of RLS symptoms.
Simultaneous administration of L-dopa and stimulants may cause increased side effects.
A single case report documented a good response of a 6-year-old boy with ADHD and RLS, who was also an MPH nonresponder, to the dopamine agonist ropinirole, in terms of ADHD as well as RLS.158
9. Premenstrual dysphoric disorder (PMDD) - 31.4 % (vs. 9.8 %)
Premenstrual dysphoric disorder (PMDD) is a severe form of premenstrual syndrome (PMS). It occurs in the days before menstruation and subsides after it begins. Symptoms are
- Mood swings
- Irritability
- Feelings of anxiety
- Concentration difficulties
- depressive moods.
PMDD was reported by 31.4% of women with a self-reported ADHD diagnosis and by 41.1% of women with a positive ADHD screening according to ASRS, compared to 9.8% of women without ADHD.159
10. Developmental disorder - 24.7 %
Developmental disability (adults with ADHD overall: 24.7 %; women 25.6 %, men 23.8 %; ADHD-I 22.6 %, ADHD-C 25.6 %, ADHD-HI 37.5 %)40
10.1. Specific developmental disorders - 37.4 % (compared to 13.4 %)
10.2. Specific developmental disorders of school skills - 23% (vs. 2.8%)
11. Autism Spectrum Disorders (ASD) - 3.6% to 85% (compared to 0.40% for girls to 1.85% for boys)
People with ADHD have a high risk of comorbid ASD.
- 15- to 21-fold risk (based on an ASD population prevalence of 1%)(meta-analysis{){Hollingdale, Woodhouse, Young, Fridman, Mandy (2019): Autistic spectrum disorder symptoms in children and adolescents with attention-deficit/hyperactivity disorder: a meta-analytical review. Psychol Med. 2019 Sep 18:1-14. doi: 10.1017/S0033291719002368.} METASTUDY}160
- 15% to 21% of children and adolescents with ADHD have an autism spectrum disorder
- Children with ADHD with ASD show stronger ADHD symptoms than children without ADHD
- 31% to 37% increased risk of ASD161
People with ADHD also have an increased risk of ADHD6162 163 It has been named with:
- 85 %160
- 26 % (study of 103 children, 85 % of whom were boys with ADHD without intellectual impairment - 27 cases were found to have previously undiagnosed ASD)164
- 21.6% of people with ADHD had comorbid ADHD165
- 3.6 % over the entire age range (cohort study)30
DSM-IV still stipulated that ADHD and autism spectrum disorders should not be diagnosed as comorbid. This was changed in DSM 5.
Girls with autism who also had ADHD showed significantly stronger symptoms of ADHD, learning disabilities and ODD than boys with ASD and ADHD in a large study.166
In the overall population, ASD occurs in 1 in 54 boys (1.85%) and 1 in 252 girls (0.40%).167
There is evidence that ADHD and autism have common genetic roots.168161 ADHD and ASD share two genes known as risk genes.162 There are suggestions that ADHD and autism may have further common genetic roots.168 Disorders of dopaminergic neurotransmission are suspected in ASD, among other things,169 while such disorders are documented in ADHD.
Around 28%170 to 50% of people with ADHD have ADHD as a comorbidity.
The fact that ADHD could not be diagnosed in autism according to DSM IV speaks against empirical experience and is therefore omitted in DSM 5.163
12. Impulse control disorder, impulse control disorder - 19.6 % (vs. 6.1 %)
- The population prevalence of impulse control disorder is 6.1%. People with ADHD have a prevalence of 19.6%, which is around 3.2 times higher.41
- Total adults 2.6 %; women 2.9 %, men 3.7 %; ADHD-I 1.2 %, ADHD-C 5.0 %, ADHD-HI 12.5 %40
13. Adjustment disorders - 18.9 % (compared to 3 %)
Adjustment disorders are described as reactions to a one-off or ongoing stressful life event.
Types of adjustment disorders are:
- Short depressive reaction
- Prolonged depressive reaction (up to 2 years)
- Mixed anxiety and depressive reaction
- With predominant impairment of other feelings
- With predominant Disorder of social behavior
- With mixed disorders of emotions and social behavior
- With other predominantly mentioned symptoms
Prevalence in the presence of ADHD:
14. Learning disorders - up to 92
14.1. Learning disorders in children - 10 to 92 %
10 - 92 %35/ general learning disability (approx. 20 %)1716
14.2. Learning disorder in adults - 2 % (compared to 1.6 %)
Total adults 1.6 %; women 1.4 %, men 2.4 %; ADHD-I 1.5 %, ADHD-C 2.5 %, ADHD-HI 2.5 %40
15. Partial performance disorders - up to 40
Source6
One study found that 6.6% of children between the ages of 7 and 11 had learning-specific partial performance disorders. Reading difficulties were found in 4%, dyscalculia in 3.6% and a weakness in written expression in 1.8%. Approximately 63% of children with learning-specific partial performance disorders had one or more comorbid diagnoses, with ADHD being the most common comorbidity at 54.9%. Boys were more frequently affected.172
15.1. Reading difficulties, dyslexia, dyslexia - 8 to 40 % (compared to 5.6 %)
A distinction must be made:
- Reading and spelling difficulties (LRS): acquired temporary weakness, usually caused by external circumstances
- Dyslexia: genetically caused disorder in the area of reading and writing that cannot be overcome through normal practice
- Dyslexia (reading difficulty): Limited ability to read and understand words or texts, despite normal vision and hearing. Tool disorder.
- Alexia: complete loss of reading ability
8 - 39 %173174 , 25 - 40 %54, 40 %68
Dyslexia and ADHD have a relevant genetic correspondence.175176 There is no evidence of mutual causality.176
One study found only weak evidence of concordant neurophysiological changes in ADHD and dyslexia.177
6-year-old children with reading difficulties are around 4 times more likely to have ADHD in the teacher assessment (21.0% instead of 5.6%) and around twice as likely to have ADHD in the parent assessment (30.5% instead of 17.8%) than children without reading difficulties.178
There is evidence that reading impairment with ADHD shows different connectivity in the brain than reading impairment without ADHD.179
65 to 70 % of all children with dyslexia are said to have functional binocular disorders:180
- Oculomotor dysfunctions (OMD) (9 %)
- Fixation impaired
- Subsequent movements impaired
- Horizontal eye saccades impaired
- Dysfunctional binocular vision (DBS) (16%)
- Heterophoria
- Suppression
- Convergence insufficiency
- Accommodative dysfunction
- Fusion insufficiency
- Stereopsis insufficient
- DBS and OMD (51 %)
- Neither DMS nor OMD (24 %)
15.2. Spelling difficulties (agraphia, dysgraphia) - 12 to 40 %
12 - 27 %171, 25 - 40 %54, 40 %68
Also for adults with ADHD.181
15.3. Dyscalculia 12 - 27 %
12 - 27 %171
A meta-analysis found that reading problems correlate more strongly with math problems than with ADHD.182
Also for adults with ADHD.181
ADHD and dyscalculia appear to have common genetic causes. No evidence of mutual causality was found176
Math performance is said to correlate less with ADHD than with executive function problems in ADHD.183 Math problems correlated with working memory problems in ADHD, but not with anxiety.184
15.4. Weakness in facial recognition (prosopagnosia)
It is unclear whether facial recognition deficits are more common in ADHD. There are sources for this185 and against it186.
15.5. Name recall weakness
A weakness in remembering names is said to occur more frequently with ADHD.185
15.6. Speech disorders
Speech disorders are said to occur more frequently with ADHD.6
15.7. Right-left weakness
Right-left weakness correlates with ADHD.187
The overall prevalence of right-left weakness among medical students was 14.7%.
16. Mental disability - 13 %
13 %68
17. Bipolar Disorders - 4.5 to 35.5 % (compared to 0.2 to 3.6 %)
Bipolar Disorder was found in
- 14.29% (men: 9.95%; women: 18.95%) of adult persons with ADHD compared to 0.72% (men: 0.53%; women 0.91%) of people without ADHD (large Swedish cohort study)29
- 10.9 % (men: 8.9 % women: 12.9 %) of adult people with ADHD compared to 1.3 % (men: 1.1 %; women: 1.6 %) of those not affected.31
- 6 %13; (adults with ADHD overall: 6.4 %; women 8.3 %, men 4.7 %; ADHD-I 5.1 %, ADHD-C 8.0 %, ADHD-HI 10.0 %)40
- 5.1% of adult psychiatric clinical patients with ADHD46
- 4.7 % (over the entire age range)30
In 2.4 million people examined, 9250 bipolar disorders were observed. If an ADHD disorder was already present, the risk of bipolar disorder increased 12-fold over a lifetime; if ADHD and an anxiety disorder were previously present, the risk increased 30-fold compared to people without ADHD and without an anxiety disorder.188
People with ADHD have an ADHD prevalence of:
- 60 % (meta-analysis of twenty studies with n = 2,722 PBD patients (average age = 12.2 years)189
- 27 % in euthymic people with ADHD190
- 25% (n = 703 adult people with ADHD), with males and BP type I more likely to have ADHD comorbidity191
- 3.06-fold increase192
A meta-analysis found Bipolar Disorder in people with ADHD and non-affected people:42
- in the total population at
- 4.48 % to 35.5 % of persons with ADHD compared to 0.2 % to 3.6 % of people without ADHD
- in clinical cases with
- 7.4 % to 80 % of persons with ADHD compared to 2 % to 19.5 % of people without ADHD
One study found evidence of overlap between the genetic causes of bipolar and ADHD, particularly in early-onset bipolar (under the age of 21),193 another study also found genetic overlap between bipolar and ADHD.194
18. Eating disorders - Loss of Control Eating Syndrome (LOC-ES) - 7.5 to 11.4 % (vs. 1.4 %)
12-fold increased risk in people with ADHD-HI.195196
A cohort study of Iranian children and adolescents found an increased prevalence of ADHD of 7.5% among people with ADHD.197
A very large study found the risk of bulimia or anorexia increased 18.3-fold with ADHD.198
Appetite disorders in adults with ADHD: 21 %
Disordered eating was 40% more common in adolescents with ADHD.199
19. Personality disorders (in adults) - 11.5 % to 33.2 % (compared to 0.9 % to 1.4 %)
Personality disorders are generally not yet diagnosed in children.
The following prevalence rates were found in adults:
- 11.5 % (men: 9.1 % women: 13.6 %) of adult people with ADHD compared to 1.4 % (men: 1.1 %; women: 1.7 %) of those not affected.31
- 33.2 % in adult persons with ADHD12 to 80.3 % in adult outpatients with ADHD200
- For non-affected persons: 0.6 %12
= 50 times the risk
A meta-analysis found personality disorders:75
- in the total population at
- 0.31 % to 33.8 % of persons with ADHD compared to 0 % to 3.9 % of people without ADHD
- in clinical cases with
- 21.9 % to 65.95 % of persons with ADHD compared to 6.6 % to 34.4 % of people without ADHD
19.1. Antisocial PS - 18 % (compared to 2 to 3.5 %)
One study found antisocial personality disorder in 18% of people with ADHD-HI with hyperactivity compared to 2% of those without.201.
Other sources cite 37.1 %20257 .
One study found Antisocial PS in 18.9% of adult persons with ADHD compared to 3.5% of non-affected people at least once in their lifetime.39
Of 30 prison inmates with ADHD-HI, 96% also had antisocial personality disorder.
In contrast, 20 non-prison ADHD-HI affected people and 18 non-affected people (without ADHD) were not found to have Antisocial Personality Disorder.Interestingly, amphetamines are the drugs most commonly used by prison inmates affected by ADHD-HI.95 Amphetamines are known to be a highly effective medication for ADHD.
For domestic violence offenders who had ADHD, ADHD treatment reduced domestic violence far more significantly than domestic violence interventions.203
19.2. Borderline PS / Emotionally unstable PS - 18 to 33 % (vs. 1 to 5 %)
Adults with ADHD are said to have BPD in 18.3% of cases204
A population study found that 33.7% of people with ADHD also had borderline personality disorder (BPD) (compared to 5.2% in the general population).39
A Swedish cohort study found a 19.4-fold risk of comorbid borderline personality disorder in people with ADHD.205 3.9% of the more than 2 million people studied had an ADHD diagnosis (women 3.0%, men 4.8%), 0.5% had BPD (women 0.8%, men 0.1%). People who had relatives with an ADHD diagnosis also had an increased risk of BPD:
- Identical twins: n = 9,130, OR = 11.2 (Among 9,130 twins, the risk of BPD was 11.2 times higher if the other twin had ADHD)
- Fraternal twins: N = 17,350, OR = 1.0
- Full siblings: n = 2,211,396, OR = 2.4
- Maternal half-siblings: n = 332,486, OR = 1.4
- Paternal half-siblings: n = 331,080; OR = 1.5
- Cousins Parents Full siblings:n = 6,456,848; OR = 1.5
- Cousins Maternal parents Half-siblings: n = 472,212; OR = 1.3
- Cousins Paternal parents Half-siblings: n = 466,836; OR = 1.2
The risk of a BPD diagnosis if the person with ADHD had ADHD themselves or a full sibling was:205
- 19.1 times higher in women (OR = 19.1)
- 21.8 times higher in men (OR = 21.8)
People with ADHD in childhood were 14% more likely to be diagnosed with BPD later in life.206
BPD in people with ADHD: 35.7%20257
In adult psychiatric clinical patients with ADHD: 30.6 %46
People with ADHD have an ADHD prevalence of 30 to 60 %.207208209210
For the differential diagnosis of ADHD / Borderline, see ⇒ Emotionally unstable personality / Borderline In the article ⇒ Differential diagnostics for ADHD in the chapter ⇒ Diagnostics.
19.3. Anxious PS - 10.6 % (vs. 2.1 %)
One study found avoidant PS in 10.6% of adult persons with ADHD compared to 2.1% of non-affected people at least once in their lifetime.39
In adult psychiatric clinical patients with ADHD: 31.6 %46
19.4. Self-insecure PS
19.5. Compulsive PS - 19.3 (vs. 7.8 %)
One study found compulsive PS in 19.3% of adult persons with ADHD compared to 7.8% of non-affected people at least once in their lifetime.39
40,7 %20257
In adult psychiatric clinical patients with ADHD: 10.2 %46
19.6. Combined PS
In adult psychiatric clinical patients with ADHD: 25.5 %46
19.7. Paranoid PS - 14.8 % (compared to 4.1 %)
20,0 %20257
One study found Paranoid PS in 14.8% of adult persons with ADHD compared to 4.1% of non-affected people at least once in their lifetime.39
19.8. Dependent PS - 3.1 % (vs. 0.4 %)
15,7 %20257
One study found Dependency PS in 3.1% of adult persons with ADHD compared to 0.4% of non-affected people at least once in their lifetime.39
In adult psychiatric clinical patients with ADHD: 18.4 %46
19.9. Narcissistic PS
15.7 %20257
One study found Narcissistic PS in 25.2% of adult persons with ADHD compared to 5.7% of non-affected people at least once in their lifetime.39
19.10. Histrionic PS (10.7 % compared to 1.6 %)
14,3 %20257
One study found Histrionic PS in 10.7% of adult persons with ADHD compared to 1.6% of non-affected people at least once in their lifetime.39
19.11. Schizotypal PS - 22.4 % (vs. 3.5 %)
8,6 %57
One study found Schizotypal PS in 22.4% of adult persons with ADHD compared to 3.5% of non-affected people at least once in their lifetime.39
Former names: Borderline schizophrenia, latent schizophrenic reaction, pseudoneurotic schizophrenia
19.12. Schizoid PS - 9.2 % (compared to 2.9 %)
6.4 %57
One study found schizoid PS in 9.2% of adult persons with ADHD compared to 2.9% of non-affected people at least once in their lifetime.39
20. Behavioral disorders / social disorders (aggression, antisocial behavior, oppositional defiant behavior) - 1.5 to 20.2 % (compared to 4.3 %)
Conduct disorder (CD): Adults with ADHD total: 1.2%; females 0.7%, males 1.7%; ADHD-I 0.3%, ADHD-C 1.0%, ADHD-HI 10.0%40
Another study found Conduct Disorder in 20.2% of adult persons with ADHD compared to 4.3% of non-affected people at least once in their lifetime.39
Oppositional defiant behavior (ODD): Adults with ADHD overall: 0.7 %; women 0.0 %, men 1.7 %; ADHD-I 0.0 %, ADHD-C 1.5 %, ADHD-HI 5.0 %40
Reduced cortisol levels have been reported in ADHD in conjunction with aggression disorders.211
Externalizing stress reactions are associated with lower basal cortisol levels and a reduced cortisol response to acute stress.
Disorders of stress hormone levels, especially cortisol, are extremely common in ADHD.
⇒ Cortisol in ADHD
21. Epilepsy - 3.4 % (compared to 0.5 to 1 %)
A meta-analysis of 63 studies with N = 1,073,188 people from 17 countries found:212
People with ADHD had an ADHD prevalence of 22.3% (12.7% for the ADHD-I subtype).
People with ADHD had an epilepsy prevalence of 3.4%.
The prevalence of ADHD is greatly increased in drug-resistant epilepsy.213
One study found that 35% of adult people with ADHD also had ADHD.214
Epilepsy and ADHD have a genetic correlation (rg=0.18), which was even stronger for focal epilepsy (rg=0.23).215
In adults with psychogenic non-epileptic seizures (PNES), ADHD was found in 63.6%, while in adults with epileptic seizures (ES), ADHD was found in 27.8%.216
Some anti-seizure medications can cause or worsen ADHD symptoms as a side effect, while some ADHD medications can increase the risk of seizures.217
The prevalence of epilepsy in the general population is 0.5 to 1 %.
44.1% of people with ADHD have at least one other mental health diagnosis in their lifetime.215
22. Schizophrenia - 3.4 % (compared to 0.8 %)
Frequency of schizophrenia in ADHD:
- 4.59-fold risk of schizophrenia with ADHD (meta-analysis, k = 12, n = 1.85 million)218
- 5.09 times the risk of a psychotic Disorder
- 4.74-fold risk of schizophrenia with ADHD diagnosed in childhood219
- 3.5% of the people with ADHD who were examined also had ADHD F 90.0, i.e. ADHD with hyperactivity, without ADHD-I (which, however, does not seem to fit in any way with the other figures mentioned in this section)
- A Norwegian cohort study found schizophrenia in 3.4 % (men: 4.2 % women: 2.5 %) of adult people with ADHD compared to 0.8 % (men: 0.9 %; women: 0.6 %) of those not affected.31
- Another study found a schizophrenia prevalence in ADHD of 0.9% across the age range30
- People with ADHD with an additional comorbidity had a 2.14-fold risk of schizophrenia compared to people with ADHD without an additional comorbidity220 The risk of schizophrenia increased further with the number of comorbidities. In particular, ASD, mental retardation, tic disorder, depression and bipolar disorder showed the strongest correlation. 73.8% of persons with ADHD who initially had no psychiatric comorbidities had other psychiatric disorders prior to the onset of schizophrenia.
The frequency of ADHD is significantly increased in schizophrenia.
- Children and adolescents with schizophrenia
- 17% to 57% have ADHD at the same time (meta-analysis, k = 5)221
- Adults with schizophrenia
- 10% to 47% have ADHD at the same time (meta-analysis, k = 5)221
- 47% reported ADHD in childhood or adulthood222
- 23% reported ADHD in childhood and adulthood222
23. Obsessive-compulsive disorder - 1.9 to 2.4 %
Obsessive-compulsive disorders are more common in adults with ADHD.6
- Adults with ADHD overall: 1.9 %; women 1.4 %, men 2.4 %; ADHD-I 0.9 %, ADHD-C 1.5 %, ADHD-HI 12.5 %40
- 2.4 % over the entire age range30
- In a large study, the prevalence of ADHD was found to be 2.19 times higher in family members of people with ADHD.223
- Of 70 adults with ADHD, 8.7% had OCD in their lifetime, compared to 5.7% of the 70 unaffected28
24. Intellectual disability - 1.4 %
Total adults 1.4 %; women 1.8 %, men 1.0 %; ADHD-I 1.2 %, ADHD-C 1.0 %, ADHD-HI 5.0 %40
25. Post-traumatic stress disorder (PTSD) - 11.9% to 28% (compared to 3.3% to 6%)
The following prevalence values of comorbid PTSD were found in people with ADHD:
METASTUDY:
- 28 to 36 % in adults with ADHD (meta-analysis, k = 21)224
Studies:
- 0.7 % Adults with ADHD in total40
- 0.7 % Women
- 0.7 % Men
- 0.9 % ADHD-I
- 0.0 % ADHD-C
- 2.5 % ADHD-HI
- 11.9 %, i.e. around 3.6 times higher.41
- 22% of adult people with ADHD39
- 26.5 % In adult psychiatric clinical patients with ADHD46
- Comorbidity of ADHD and PTSD occurred 32% more frequently in women than in men, but only in adults (meta-analysis, k = 13, n = 13,585225
PTSD is associated with a greatly increased risk of ADHD (up to + 153 %)
- 2.53-fold risk of ADHD (+153%) in war veterans with previous PTSD226
- 2.19-fold ADHD risk (+ 119%) in war veterans with existing PTSD226
26. Tic disorders 30 % (compared to 5 %)
About 30% of all patients with ADHD have tics or Tourette syndrome, while about half of all patients with a tic disorder or TS also have ADHD.227
The population prevalence of tic disorders is around 5%228
27. Migraine
Source163
28. Obesity
2.1-fold risk for people with ADHD.229
ne study found that gene variants that correlate with obesity can causally increase the risk of ADHD.113
For treatment options, see below under 4.5.
29. Socialization disorder
Source6
30. Disorder of sexual development
Source6
- Earlier onset of sexual activity
- More sexual partners
- Less time with a partner230
- Higher rate of contraception230
- High rate of unwanted pregnancies
- Teenage pregnancies 5.5 times231
- Teenage pregnancies of mothers with ADHD: 15.3%
- Teenage pregnancies of mothers without ADHD: 2.8%
- Birth rate increased (42:1)230
= 42 times the risk - Higher risk of sexually transmitted diseases
31. Narcolepsy
A meta-analysis found that around 33% of people with narcolepsy also have ADHD.9
32. Messi syndrome / Hoarding
Messi syndrome is characterized by a strong urge to collect useless objects with a tendency to litter the living environment. A strong coincidence with ADHD is discussed.232 An overview of the literature can be found in Kuwano et al.233 They found a comorbidity of ADHD in 26.7% of people with ADHD.
33. Attachment disorders
Source6
One study found that gene variants that correlate with increased social interaction are a protective factor against ADHD.113
34. Enuresis (enuresis)
Source6
Enuresis in children increased the risk of comorbid ADHD by 2.15-fold (OR 3.15).234
35. Encopresis (defecation)
Source6
36. Suicidal tendencies - 2.4 to 6.7-fold
A meta-analysis of 57 studies found a correlation between ADHD and235
- Suicide attempts (OR 2.37)
- Suicidal thoughts (OR 3.53)
- Suicide plans (OR 4.54)
- Suicide (OR 6.69).
According to the study, suicide is between 2.37 and 6.69 times more common in people with ADHD than in those without the disorder.
Another study found increased suicidality in children and adolescents with ADHD (OR 1.1), but this was mediated by comorbid depression, irritability and anxiety, not ADHD itself.236
37. Fibromyalgia - 4-fold
One study found a fourfold frequency of ADHD in people with fibromyalgia, without quantifying the frequency of fibromyalgia in people with ADHD.237
38. Chew nails
A study examined 450 children. 14% of them bit their nails. Among these were found:238
- ADHD at 74.6 %
- Oppositional defiant behavior at 36
- Separation anxiety at 20.6 %
- Enuresis at 15.6 %
- Tic disorders at 12.7 %
- Obsessive-compulsive disorder at 11.1
- mental retardation at 9.5 %
- major depressive disorders at 6.7 %
profound developmental disorders at 3.2 %.
39. Mental disorders in relatives of people with ADHD - 6.8-fold
An analysis of the entire Taiwanese population in 2010 examined 220,966 parents of children with ADHD-HI (according to ICD-9, which did not recognize ADHD-I), 174,460 siblings of children with ADHD-HI, and 5,875 children of parents with ADHD-HI. Among these relatives of people with ADHD-HI, the risk of severe psychiatric disorders was significantly increased compared to matched control subjects without relatives with ADHD-HI:239
- ADHD-HI: 6.87-fold risk
- Autism spectrum disorder: 4.14 times the risk
- Bipolar disorders: 2.21 times the risk
- Major depressive disorders: 2.08 times the risk
- Schizophrenia: 1.69 times the risk
This can be understood as an indication of common genetic causes. However, it is also theoretically conceivable that this could be explained by the immunological consequences of (primarily viral) infections (which are more frequently transmitted between close relatives). See the chapter ⇒ Immune system and behavior.
Similarly, similar external life circumstances and similar dysfunctional behavior patterns and stressful experiences are likely to be shared more frequently among close people. These mechanisms can complement each other.
40. Psychoses - 8.8 % (compared to 3 %)
One study found psychosis in 8.8% of adult persons with ADHD compared to 3% of non-affected people at least once in their lifetime.39
41. Dopamine transporter deficiency syndrome (DTDS)
Dopamine transporter deficiency syndrome (DTDS) is also known as infantile parkinsonism-dystonia.
Prevalence: very rare. To date, 60 people with ADHD are known.240
DTDS is a hereditary genetic disorder with a dysfunctional dopamine transporter.
The classic early-onset DTDS occurs within the first 6 months of life. Rarely, there is late-onset DTDS, which only becomes apparent in adolescence or adulthood.240
Classic early-onset DTDS:240
- Onset in the first 6 months (infants)
- unspecific symptoms
- Irritability
- Difficulties with breastfeeding
- axial hypotension
- delayed motor development
- consequences of a hyperkinetic movement disorder
- with characteristics of
- Chorea
- Dystonia
- Ballism
- orolingual dyskinesia
- with characteristics of
- In the course of time
- Parkinsonism-dystonia complex
- Bradykinesia, progressing to akinesia
- dystonic posture
- distal tremor
- Rigidity
- diminished facial expressions
- severe motor delay due to restriction of voluntary movements
- Episodic status dystonicus
- Exacerbations of dystonia
- secondary orthopaedic, gastrointestinal and respiratory complications
- Parkinsonism-dystonia complex
- usually relative preservation of intelligence with good cognitive development
Atypical late-onset DTDS240
- Onset in childhood to adulthood (4th decade of life)
- in 5 of the 60 known people with ADHD
- Infancy and toddlerhood:
- Normal psychomotor development
- Childhood
- ADHD or individual ADHD symptoms
- late onset
- Parkinsonism dystonia with
- Tremor
- progressive bradykinesia
- variable tone
- dystonic posture
- Parkinsonism dystonia with
Diagnostics:240
Cerebrospinal fluid (CSF) almost always shows
- HVA:5-HIAA ratio in SLC6A3-related DTDS is >4.0 (5.0-13.0) (normal range 1.0-4.0).
- increased homovanillic acid levels (HVA, a metabolite derived from dopamine)
- normal 5-hydroxyindoleacetic acid level (5-HIAA, a metabolite derived from serotonin)
- Pterin normal
- SPECT imaging using the ligand Ioflupane (DaTSCAN):
- very abnormal results with absent/reduced tracer uptake in the basal ganglia
- Genetic analysis
- Presence of a heterozygous dominant-negative SLC6A3 pathogenic variant known to cause autosomal dominant DTDS
- e.g. p.Lys619Asn
- Presence of a heterozygous dominant-negative SLC6A3 pathogenic variant known to cause autosomal dominant DTDS
42. Stuttering
One study reports an ADHD prevalence of 50% in children and adolescents who stutter.241
Schmidt, Waldmann, Petermann, Brähler (2010): Wie stark sind Erwachsene mit ADHS und komorbiden Störungen in ihrer gesundheitsbezogenen Lebensqualität beeinträchtigt? Zeitschrift für Psychiatrie, Psychologie und Psychotherapie, 58, 9–21, zitiert nach Schmidt, Petermann: ADHS über die Lebensspanne – Symptome und neue diagnostische Ansätze, Zeitschrift für Psychiatrie, Psychologie und Psychotherapie, 59 (3), 2011, 227–238, Seite 229 ↥ ↥
Merrill RM, Merrill AW, Madsen M (2022): Attention-Deficit Hyperactivity Disorder and Comorbid Mental Health Conditions Associated with Increased Risk of Injury. Psychiatry J. 2022 Oct 14;2022:2470973. doi: 10.1155/2022/2470973. PMID: 36277995; PMCID: PMC9586798. ↥ ↥
Okada T, Sotodate T, Ogasawara-Shimizu M, Nishigaki N (2024): Psychiatric comorbidities of attention deficit/hyperactivity disorder in Japan: a nationwide population-based study. Front Psychiatry. 2024 Oct 24;15:1359872. doi: 10.3389/fpsyt.2024.1359872. PMID: 39512898; PMCID: PMC11541049. ↥
ADHS, iPads, Schlaf und Konzentrationsprobleme: Im Licht neuer Erkenntnisse ↥
Sung, Hiscock, Sciberras, Efron (2008): Sleep problems in children with attention-deficit/hyperactivity disorder: prevalence and the effect on the child and family; Arch Pediatr Adolesc Med. 2008 Apr;162(4):336-42. doi: 10.1001/archpedi.162.4.336. n = 239 ↥
Edel, Vollmoeller: Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung bei Erwachsenen, 2006, Seite 53, ohne %-Angabe ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Kostanecka-Endress, Woerner, Hajak, Rothenberger (2008): Tag und Nacht in Bewegung – Schlafverhalten hypermotorischer Kinder Tourette-Syndrom und hyperkinetisches Syndrom; Monatsschrift Kinderheilkunde; December 2000, Volume 148, Issue 12, pp 1113–1128; zitiert nach Steinhausen, Rothenberger, Döpfner (Herausgeber) (2010): Handbuch ADHS; Grundlagen, Klinik, Therapie und Verlauf der Aufmerksamkeitsdefizit-Hyperaktivitätsstörung, Kohlhammer, Seite 187 ↥
Schlüter, Buschatz, Kahlen, Dieffenbach, Trowitzsch (1999): Polysomnographie bei aufmerksamkeitsgestörten und hyperaktiven Kindern (Attention Deficit Hyperactivity Disorder, ADHD); Somnologie – Schlafforschung und Schlafmedizin, May 1999, Volume 3, Issue 3, pp 140–147 ↥
Kim, Lee, Sung, Jung, Pak (2019): Prevalence of attention deficit hyperactivity disorder symptoms in narcolepsy: a systematic review. Sleep Med. 2019 Aug 3;65:84-88. doi: 10.1016/j.sleep.2019.07.022. ↥ ↥ ↥
Nishino, Sakai (2016): Modulations of Ventral Tegmental Area (VTA) Dopaminergic Neurons by Hypocretins/Orexins: Implications in Vigilance and Behavioral Control In: Monti, Pandi-Perumal, Chokroverty (Herausgeber) (2016): Dopamine and Sleep: Molecular, Functional, and Clinical Aspects, 65-90, 75 ↥
Oehler (2009), Vortrag beim 4. ADHS-Gipfel in Hamburg, 06.-08.02.2009 mit Verweis auf Schlander, Schwarz, Trott, Viapiano, Bonauer (2007): Who cares for patients with attention-deficit/hyperactivity disorder (ADHD)? Insights from Nordbaden (Germany) on administrative prevalence and physician involvement in health care provision; N.Eur Child Adolesc Psychiatry. 2007 Oct;16(7):430-8. ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Müller, Candrian, Kropotov (2011): ADHS – Neurodiagnostik in der Praxis, S. 17 ↥ ↥ ↥ ↥ ↥
Prävalenz von Schlafstörungen unter Erwerbstätigen in Deutschland nach Geschlecht und Altersgruppe im Jahr 2008, Statista ↥
Shen, Li, Xue, Li, Li, Jiang, Sheng, Wang (2022): Nutritional complexity in children with ADHD related morbidities in China: A cross-sectional study. Asia Pac J Clin Nutr. 2022 Mar;31(1):108-117. doi: 10.6133/apjcn.202203_31(1).0012. PMID: 35357109. ↥
Edel, Vollmoeller: Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung bei Erwachsenen, Springer, 2006, Seite 40, unter Bezug auf Krause et al. 1998. ↥
Leitlinie der Arbeitsgemeinschaft ADHS der Kinder- und Jugendärzte e.V., Stand 2014 ↥
https://www.klinikum.uni-heidelberg.de/AG-Anaesthesie-und-Schlafapnoe.114157.0.html, nicht mehr online ↥
Smith, Gozal, Hunter, Kheirandish-Gozal (2017): Parent-Reported Behavioral and Psychiatric Problems Mediate the Relationship between Sleep-Disordered Breathing and Cognitive Deficits in School-Aged Children. Front Neurol. 2017 Aug 11;8:410. doi: 10.3389/fneur.2017.00410. eCollection 2017. ↥
Hudgins (2003): Experiential Treatment for PTSD. New York, NY: Springer Publishing Company, zitiert nach Böhm (2010/2012): Erfahrungen mit “SynestheticProcessing”/emoflex©; Heft 4/2010 „neuenAkzente“ des ADHS Deutschland e.V. ↥ ↥
Tempesta, Couyoumdjian, Curcio, Moroni, Marzano, De Gennaro, Ferrara (2010): Lack of sleep affects the evaluation of emotional stimuli. BrainRes Bull, n = 40 ↥ ↥
Böhm (2010/2012): Erfahrungen mit “SynestheticProcessing”/emoflex©; Heft 4/2010 „neuenAkzente“ des ADHS Deutschland e.V. ↥
Kooij, Huss, Asherson, Akehurst, Beusterien, French, Sasané, Hodgkins (2012): Distinguishing comorbidity and successful management of adult ADHD. J Atten Disord. 2012 Jul;16(5 Suppl):3S-19S. doi: 10.1177/1087054711435361. ↥ ↥
Steinhausen, Rothenberger, Döpfner (Herausgeber) (2020): Handbuch ADHS; Grundlagen, Klinik, Therapie und Verlauf der Aufmerksamkeitsdefizit-Hyperaktivitätsstörung, Seite 204 ↥
Pranjić M, Rahman N, Kamenetskiy A, Mulligan K, Pihl S, Arnett AB (2023): A systematic review of behavioral and neurobiological profiles associated with coexisting attention-deficit/hyperactivity disorder and developmental coordination disorder. Neurosci Biobehav Rev. 2023 Sep 12;153:105389. doi: 10.1016/j.neubiorev.2023.105389. PMID: 37704094. REVIEW ↥ ↥
Zentrales ADHS-Netz: Allgemeine Infos zu ADHS; “Welche weiteren komorbiden Probleme gibt es?” ↥
Sobanski E, Brüggemann D, Alm B, Kern S, Deschner M, Schubert T, Philipsen A, Rietschel M (2007): Psychiatric comorbidity and functional impairment in a clinically referred sample of adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci. 2007 Oct;257(7):371-7. doi: 10.1007/s00406-007-0712-8. PMID: 17902010. n = 140 ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Chen, Hartman, Haavik, Harro, Klungsøyr, Hegvik, Wanders, Ottosen, Dalsgaard, Faraone, Larsson (2018): Common psychiatric and metabolic comorbidity of adult attention-deficit/hyperactivity disorder: A population-based cross-sectional study. PLoS One. 2018 Sep 26;13(9):e0204516. doi: 10.1371/journal.pone.0204516. PMID: 30256837; PMCID: PMC6157884. n = 5.551.807, 18 bis 64 Jahre ↥ ↥ ↥ ↥
Merrill RM, Merrill AW, Madsen M (2022): Attention-Deficit Hyperactivity Disorder and Comorbid Mental Health Conditions Associated with Increased Risk of Injury. Psychiatry J. 2022 Oct 14;2022:2470973. doi: 10.1155/2022/2470973. PMID: 36277995; PMCID: PMC9586798. n = 382.488 ↥ ↥ ↥ ↥ ↥ ↥ ↥
Solberg BS, Halmøy A, Engeland A, Igland J, Haavik J, Klungsøyr K (2018): Gender differences in psychiatric comorbidity: a population-based study of 40 000 adults with attention deficit hyperactivity disorder. Acta Psychiatr Scand. 2018 Mar;137(3):176-186. doi: 10.1111/acps.12845. PMID: 29266167; PMCID: PMC5838558. ↥ ↥ ↥ ↥ ↥
Roy, Oldehinkel, Verhulst; Ormel, Hartman (2014): Anxiety and disruptive behavior mediate pathways from attention-deficit/hyperactivity disorder to depression; J Clin Psychiatry. 2014 Feb;75(2):e108-13. doi: 10.4088/JCP.13m08648.; n = 1584 ↥ ↥
Schlander, Schwarz, Trott, Viapiano, Bonauer (2007): Who cares for patients with attention-deficit/hyperactivity disorder (ADHD)? Insights from Nordbaden (Germany) on administrative prevalence and physician involvement in health care provision; N.Eur Child Adolesc Psychiatry. 2007 Oct;16(7):430-8., zitiert nach Oehler (2009), Vortrag beim 4. ADHS-Gipfel in Hamburg, 06.-08.02.2009 ↥ ↥
Adzrago D, Sulley S, Williams F (2025): Mental health in children with and without ADHD: the role of physical activity and parental nativity. Child Adolesc Psychiatry Ment Health. 2025 Jan 18;19(1):2. doi: 10.1186/s13034-025-00859-8. PMID: 39827157; PMCID: PMC11743031. ↥ ↥ ↥
Häufigkeit der Komorbidität bei Kindern mit AD(H)S nach Hudziak und Todd, 2001, zitiert aus Müller, Candrian, Kropotov (2011): ADHS – Neurodiagnostik in der Praxis, S. 16 ↥ ↥ ↥ ↥
adhs-chaoten; Thread: ADS / ADHS und saisonale Depression / Winterdepression ↥
Philipsen, Heßlinger, Tebartz van Elst: AufmerksamkeitsdefizitHyperaktivitätsstörung im Erwachsenenalter – Diagnostik, Ätiologie und Therapie (ÜBERSICHTSARBEIT), Deutsches Ärzteblatt, Jg. 105, Heft 17, 25. April 2008, Seite 311 – 317, 313 , Seite 313 unter Verweis auf Rösler, Heßlinger, Philipsen (2007): ADHS im Erwachsenenalter. In: Voderholzer, Hohagen (Hrsg.): Therapie psychischer Erkrankungen – State of the Art. 2. Auflage. München: Urban & Fischer, 2007 ↥ ↥
Faraone, APA 2006: Massachusetts General Hospital Study, zitiert nach Oehler (2009), Vortrag beim 4. ADHS-Gipfel in Hamburg, 06.-08.02.2009 ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Bernardi S, Faraone SV, Cortese S, Kerridge BT, Pallanti S, Wang S, Blanco C (2012): The lifetime impact of attention deficit hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Psychol Med. 2012 Apr;42(4):875-87. doi: 10.1017/S003329171100153X. PMID: 21846424; PMCID: PMC3383088. n = 34.000 ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Ohnishi, Kobayashi, Yajima, Koyama, Noguchi (2020): Psychiatric Comorbidities in Adult Attention-deficit/Hyperactivity Disorder: Prevalence and Patterns in the Routine Clinical Setting. Innov Clin Neurosci. 2019 Sep 1;16(9-10):11-16. PMID: 32082943; PMCID: PMC7009330. n = 575 ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Endrass, G (2024): ADHS aktuell – Mythen und Bedenken versus Fakten; NeuroTransmitter 2024; 35 (1-2) ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Choi WS, Woo YS, Wang SM, Lim HK, Bahk WM (2022): The prevalence of psychiatric comorbidities in adult ADHD compared with non-ADHD populations: A systematic literature review. PLoS One. 2022 Nov 4;17(11):e0277175. doi: 10.1371/journal.pone.0277175. PMID: 36331985; PMCID: PMC9635752. ↥ ↥ ↥
Lundin C, Wikman A, Wikman P, Kallner HK, Sundström-Poromaa I, Skoglund C (2023): Hormonal Contraceptive Use and Risk of Depression Among Young Women With Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 2023 Jun;62(6):665-674. doi: 10.1016/j.jaac.2022.07.847. PMID: 36332846. n = 792.913 ↥
Orsolini L, Longo G, Volgare R, Piergentili S, Servasi M, Perugi G, Volpe U (2024): Cyclothymic affective temperament and low positive attitude coping strategies as predictors of comorbid depressive symptomatology in adult ADHD patients. J Affect Disord. 2024 Nov 15;365:417-426. doi: 10.1016/j.jad.2024.08.083. PMID: 39154981. ↥
Callovini T, Di Nicola M, Pepe M, Crocamo C, Bartoli F, Sani G, Carrà G (2024): Influence of temperament and emotional dysregulation on depressive symptoms in adults with attention-deficit/hyperactivity disorder: A structural equation modelling analysis. J Psychiatr Res. 2024 Dec;180:227-233. doi: 10.1016/j.jpsychires.2024.10.019. PMID: 39454489. ↥
Miesch, Deister (2018): Die Aufmerksamkeitsdefizit- und Hyperaktivitätsstörung (ADHS) in der Erwachsenenpsychiatrie: Erfassung der ADHS-12-Monatsprävalenz, der Risikofaktoren und Komorbidität bei ADHS; Attention-deficit/hyperactivity disorder (ADHD) in adult psychiatry: Data on 12-month prevalence, risk factors and comorbidity; Fortschr Neurol Psychiatr. 2018 Feb 28. doi: 10.1055/s-0043-119987. DOI: 10.1055/s-0043-119987, n = 166 ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Chang KD, Steiner H, Ketter TA (2000): Psychiatric phenomenology of child and adolescent bipolar offspring. J Am Acad Child Adolesc Psychiatry. 2000 Apr;39(4):453-60. doi: 10.1097/00004583-200004000-00014. PMID: 10761347. ↥
Shankman, Lewinsohn, Klein, Small, Seeley, Altman (2009): Subthreshold conditions as precursors for full syndrome disorders: A 15-year longitudinal study of multiple diagnostic classes. Journal of Child Psychology and Psychiatry, 50, 1485–1494, zitiert nach Schmidt, Petermann: ADHS über die Lebensspanne – Symptome und neue diagnostische Ansätze, Zeitschrift für Psychiatrie, Psychologie und Psychotherapie, 59 (3), 2011, 227–238, Seite 232 ↥
Masi, Manfredi, Nieri, Muratori, Pfanner, Milone (2017): A Naturalistic Comparison of Methylphenidate and Risperidone Monotherapy in Drug-Naive Youth With Attention-Deficit/Hyperactivity Disorder Comorbid With Oppositional Defiant Disorder and Aggression. J Clin Psychopharmacol. 2017 Aug 10. doi: 10.1097/JCP.0000000000000747; n = 40 ↥ ↥
Müller, Candrian, Kropotov (2011): ADHS – Neurodiagnostik in der Praxis, mit Verweis auf Hudziak, Todd 2001 ↥
Mohammadi, Zarafshan, Khaleghi, Ahmadi, Hooshyari, Mostafavi, Ahmadi, Alavi, Shakiba, Salmanian (2019): Prevalence of ADHD and Its Comorbidities in a Population-Based Sample. J Atten Disord. 2019 Dec 13:1087054719886372. doi: 10.1177/1087054719886372. n = 30.532 ↥ ↥ ↥
Gnanavel, Sharma, Kaushal, Hussain (2019): Attention deficit hyperactivity disorder and comorbidity: A review of literature. World J Clin Cases. 2019 Sep 6;7(17):2420-2426. doi: 10.12998/wjcc.v7.i17.2420. ↥ ↥ ↥
Sagar-Ouriaghli, Milavic, Barton, Heaney, Fiori, Lievesley, Singh, Santosh (2018): Comparing the DSM-5 construct of Disruptive Mood Dysregulation Disorder and ICD-10 Mixed Disorder of Emotion and Conduct in the UK Longitudinal Assessment of Manic Symptoms (UK-LAMS) Study. Eur Child Adolesc Psychiatry. 2018 Sep;27(9):1095-1104. doi: 10.1007/s00787-018-1149-5. ↥
Kain, Landerl, Kaufmann (2008): Komorbidität bei ADHS. Monatsschrift Kinderheilkunde,156, 757 – 767, zitiert nach Rothenberger, Lauth, Ramacher-Faasen, Braun, Bock, von Aster, von Aster, von Aster in Lernen und Lernstörungen (2014), 3, pp. 185-202. DOI: 10.1024/2235-0977/a000071: Kommentare zu Romanos & Jans (2014). ADHS – an der Nahtstelle von Medizin und Pädagogik. Lernen und Lernstörungen, 3, 117 – 132; DOI: http://dx.doi.org/10.1024/2235-0977/a000071 ↥ ↥ ↥
Schmidt, S., Waldmann, H.-C., Petermann, F. & Brähler, E. (2010). Wie stark sind Erwachsene mit ADHS und komorbiden Störungen in ihrer gesundheitsbezogenen Lebensqualität beeinträchtigt? Zeitschrift für Psychiatrie, Psychologie und Psychotherapie, 58, 9–21, zitiert nach Schmidt, Petermann: ADHS über die Lebensspanne – Symptome und neue diagnostische Ansätze, Zeitschrift für Psychiatrie, Psychologie und Psychotherapie, 59 (3), 2011, 227–238, Seite 229 ↥ ↥ ↥
Schlander, Schwarz, Trott, Viapiano, Bonauer (2007): Who cares for patients with attention-deficit/hyperactivity disorder (ADHD)? Insights from Nordbaden (Germany) on administrative prevalence and physician involvement in health care provision; N.Eur Child Adolesc Psychiatry. 2007 Oct;16(7):430-8. ↥ ↥
Oehler (2009), Vortrag beim 4. ADHS-Gipfel in Hamburg, 06.-08.02.2009 ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Schmidt, Petermann: ADHS über die Lebensspanne – Symptome und neue diagnostische Ansätze, Zeitschrift für Psychiatrie, Psychologie und Psychotherapie, 59 (3), 2011, 227–238 ↥
Mayes SD, Pardej SK, Waschbusch DA (2024): Oppositional Defiant Disorder in Autism and ADHD. J Autism Dev Disord. 2024 Jul 27. doi: 10.1007/s10803-024-06437-9. PMID: 39066970. n = 2.400 ↥ ↥ ↥ ↥ ↥
Biederman J (2005): Attention-deficit/hyperactivity disorder: a selective overview. Biol Psychiatry. 2005 Jun 1;57(11):1215-20. doi: 10.1016/j.biopsych.2004.10.020. PMID: 15949990. REVIEW ↥ ↥ ↥
Steinhausen, Rothenberger, Döpfner (Herausgeber) (2010): Handbuch ADHS; Grundlagen, Klinik, Therapie und Verlauf der Aufmerksamkeitsdefizit-Hyperaktivitätsstörung, Kohlhammer, Seite 173 ↥
Sonuga-Barke, Bitsakou, Thompson (2010): Beyond the dual pathway model: Evidence for the dissociation of timing, inhibitory and delay-related impairments in Attention Deficit/Hyperactivity Disorder. ↥
Witthöft, Koglin, Petermann (2010): Zur Komorbidität von aggressivem Verhalten und ADHS. Kindheit und Entwicklung, 19, 218–227, zitiert nach Schmidt, Petermann: ADHS über die Lebensspanne – Symptome und neue diagnostische Ansätze, Zeitschrift für Psychiatrie, Psychologie und Psychotherapie, 59 (3), 2011, 227–238, Seite 232 ↥
Salmanian, Mohammadi, Hooshyari, Mostafavi, Zarafshan, Khaleghi, Ahmadi, Alavi, Shakiba, Rahgozar, Safavi, Arman, Delpisheh, Mohammadzadeh, Hosseini, Ostovar, Hojjat, Armani, Talepasand, Amiri (2019): Prevalence, comorbidities, and sociodemographic predictors of conduct disorder: the national epidemiology of Iranian children and adolescents psychiatric disorders (IRCAP). Eur Child Adolesc Psychiatry. 2019 Dec 6. doi: 10.1007/s00787-019-01448-9. ↥
Beesdo K, Knappe S, Pine DS (2009): Anxiety and anxiety disorders in children and adolescents: developmental issues and implications for DSM-V. Psychiatr Clin North Am. 2009 Sep;32(3):483-524. doi: 10.1016/j.psc.2009.06.002. PMID: 19716988; PMCID: PMC3018839. REVIEW ↥
Strawn JR, Geracioti L, Rajdev N, Clemenza K, Levine A (2018): Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review. Expert Opin Pharmacother. 2018 Jul;19(10):1057-1070. doi: 10.1080/14656566.2018.1491966. PMID: 30056792; PMCID: PMC6340395. REVIEW ↥
Deng X, Ren H, Wu S, Jie H, Gu C (2024): Exploring the genetic and socioeconomic interplay between ADHD and anxiety disorders using Mendelian randomization. Front Psychiatry. 2024 Aug 6;15:1439474. doi: 10.3389/fpsyt.2024.1439474. PMID: 39165506; PMCID: PMC11333326. ↥
Steinhausen, Rothenberger, Döpfner (Herausgeber) (2010): Handbuch ADHS; Grundlagen, Klinik, Therapie und Verlauf der Aufmerksamkeitsdefizit-Hyperaktivitätsstörung, Kohlhammer, Seite 174 ↥ ↥ ↥ ↥
D’Agati, Curatolo, Mazzone (2019): Comorbidity between ADHD and anxiety disorders across the lifespan. Int J Psychiatry Clin Pract. 2019 Jun 24:1-7. doi: 10.1080/13651501.2019.1628277. ↥ ↥
Edel, Vollmoeller: Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung bei Erwachsenen, 2006, Seite 53 ↥
Wancata, Freidl, Fabrian (2011): Epidemiologie der Angststörungen, Journal für Neurologie Neurochirurgie und Psychiatrie, 2011; 12 (4), 332-335 ↥
Murray, Caye, McKenzie, Auyeung, Murray, Ribeaud, Freeston, Eisner (2020): Reciprocal Developmental Relations Between ADHD and Anxiety in Adolescence: A Within-Person Longitudinal Analysis of Commonly Co-Occurring Symptoms. J Atten Disord. 2020 Mar 14:1087054720908333. doi: 10.1177/1087054720908333. PMID: 32172640. ↥ ↥
Fuller-Thomson, Carrique, MacNeil (2021): Generalized anxiety disorder among adults with attention deficit hyperactivity disorder. J Affect Disord. 2021 Nov 16:S0165-0327(21)01096-X. doi: 10.1016/j.jad.2021.10.020. PMID: 34799150. n = 6.989 ↥
Wang F, Yang H, Li F, Zheng Y, Xu H, Wang R, Li Y, Cui Y (2024): Prevalence and comorbidity of anxiety disorder in school-attending children and adolescents aged 6-16 years in China. BMJ Paediatr Open. 2024 Mar 27;8(1):e001967. doi: 10.1136/bmjpo-2023-001967. PMID: 38538104; PMCID: PMC10982779. ↥
Choi WS, Woo YS, Wang SM, Lim HK, Bahk WM (2022): The prevalence of psychiatric comorbidities in adult ADHD compared with non-ADHD populations: A systematic literature review. PLoS One. 2022 Nov 4;17(11):e0277175. doi: 10.1371/journal.pone.0277175. PMID: 36331985; PMCID: PMC9635752. METASTUDIE ↥ ↥
Hernández M, Levin FR, Campbell ANC (2025): ADHD and Alcohol Use Disorder: Optimizing Screening and Treatment in Co-occurring Conditions. CNS Drugs. 2025 May;39(5):457-472. doi: 10.1007/s40263-025-01168-6. PMID: 39979544. REVIEW ↥
McMahon C, Schweinle W, Anand V (2024): Substance Use Disorder in Adults with ADHD in South Dakota. S D Med. 2024 Aug;77(8):342-348. PMID: 39311728. ↥
Koura S, White A, Masdon J, Brewer KL, Parker-Cote JL, Meggs WJ (2023): Retrospective chart review of substance abuse in patients with psychiatric emergencies in an emerging urban county. J Am Coll Emerg Physicians Open. 2023 Aug 17;4(4):e13028. doi: 10.1002/emp2.13028. PMID: 37600902; PMCID: PMC10435894. ↥ ↥
Solberg BS, Halmøy A, Engeland A, Igland J, Haavik J, Klungsøyr K (2018): Gender differences in psychiatric comorbidity: a population-based study of 40 000 adults with attention deficit hyperactivity disorder. Acta Psychiatr Scand. 2018 Mar;137(3):176-186. doi: 10.1111/acps.12845. PMID: 29266167; PMCID: PMC5838558. n = 1.701.206 ↥
Md Yusop MR, Mohamed S, Jaris NH, Jamal A (2024): Factors associated with attention deficit hyperactivity disorder symptoms among patients with substance use in Malaysia. East Asian Arch Psychiatry. 2024 Dec;34(4):91-102. doi: 10.12809/eaap2426. PMID: 39743482. ↥
Lastres-Becker I, Cebeira M, de Ceballos ML, Zeng BY, Jenner P, Ramos JA, Fernández-Ruiz JJ (2001): Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson’s syndrome and of MPTP-treated marmosets. Eur J Neurosci. 2001 Dec;14(11):1827-32. doi: 10.1046/j.0953-816x.2001.01812.x. PMID: 11860478. ↥
Mailleux P, Vanderhaeghen JJ (1993): Dopaminergic regulation of cannabinoid receptor mRNA levels in the rat caudate-putamen: an in situ hybridization study. J Neurochem. 1993 Nov;61(5):1705-12. doi: 10.1111/j.1471-4159.1993.tb09807.x. PMID: 7901331. ↥
Romero J, Berrendero F, Pérez-Rosado A, Manzanares J, Rojo A, Fernández-Ruiz JJ, de Yebenes JG, Ramos JA (2000): Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased CB1 receptor mRNA levels in the caudate-putamen. Life Sci. 2000;66(6):485-94. doi: 10.1016/s0024-3205(99)00618-9. PMID: 10794065. ↥
Rohner H, Gaspar N, Philipsen A, Schulze M (2023): Prevalence of Attention Deficit Hyperactivity Disorder (ADHD) among Substance Use Disorder (SUD) Populations: Meta-Analysis. Int J Environ Res Public Health. 2023 Jan 10;20(2):1275. doi: 10.3390/ijerph20021275. PMID: 36674031; PMCID: PMC9859173. METASTUDIE ↥
Victor R, Gondwal R, Avinash P, Singhania R (2023): Decoding the link between substance dependence and attention deficit hyperactivity disorder in adults: A cross-sectional study from North India. Ind Psychiatry J. 2023 Jul-Dec;32(2):397-401. doi: 10.4103/ipj.ipj_47_23. PMID: 38161447; PMCID: PMC10756592. ↥
Beslot A, Grall-Bronnec M, Balem M, Schreck B, Laforgue EJ, Victorri-Vigneau C, Guillou-Landreat M, Leboucher J; OPAL-Group; Challet-Bouju G, Cabelguen C (2024): ADHD: prevalence and effect on opioid use disorder treatment outcome in a French sample of patients receiving medication for opioid use disorder-the influence of impulsivity as a mediating factor. Harm Reduct J. 2024 Sep 9;21(1):165. doi: 10.1186/s12954-024-01079-7. PMID: 39252018; PMCID: PMC11382469. ↥
Edel, Vollmoeller: Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung bei Erwachsenen, 2006, Seite 107 f ↥
Manni, Cipollone, Pallucchini, Maremmani, Perugi, Maremmani (2019): Remarkable Reduction of Cocaine Use in Dual Disorder (Adult Attention Deficit Hyperactive Disorder/Cocaine Use Disorder) Patients Treated with Medications for ADHD. Int J Environ Res Public Health. 2019 Oct 15;16(20). pii: E3911. doi: 10.3390/ijerph16203911. ↥ ↥
Heradstveit, Skogen, Hetland, Stewart, Hysing (2019): Psychiatric Diagnoses Differ Considerably in Their Associations With Alcohol/Drug-Related Problems Among Adolescents. A Norwegian Population-Based Survey Linked With National Patient Registry Data. Front Psychol. 2019 May 8;10:1003. doi: 10.3389/fpsyg.2019.01003. eCollection 2019. n = 9.408 ↥ ↥
August, Winters, Realmuto, Fahnhorst, Botzet, Lee (2006): Prospective study of adolescent drug use among community samples of ADHD and non-ADHD participants. J Am Acad Child Adolesc Psychiatry. 2006 Jul;45(7):824-32. doi: 10.1097/01.chi.0000219831.16226.f8. PMID: 16832319. n = 199 ↥
Müller, Candrian, Kropotov (2011): ADHS – Neurodiagnostik in der Praxis, S. 88 ↥
Pomerleau, Downey, Stelson, Pomerleau (1995): Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder, Journal of Substance Abuse, Volume 7, Issue 3, 1995, Pages 373-378, ISSN 0899-3289, https://doi.org/10.1016/0899-3289(95)90030-6. ↥
Lambert, Hartsough, (1998): Prospective Study of Tobacco Smoking and Substance Dependencies Among Samples of ADHD and Non-ADHD Participants. Journal of Learning Disabilities, 31(6), 533–544. https://doi.org/10.1177/002221949803100603 ↥
Kollins, McClernon, Fuemmeler (2005): Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults. Arch Gen Psychiatry. 2005 Oct;62(10):1142-7. ↥
http://de.statista.com/statistik/daten/studie/261015/umfrage/praevalenz-des-rauchens-in-deutschland-nach-geschlecht/ ↥ ↥
Edel, Vollmoeller: Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung bei Erwachsenen, 2006, Seite 106 ↥ ↥
Steinhausen, Rothenberger, Döpfner (2010): Handbuch ADHS, Seite 78 ↥
Roman ML, Vansteene C, Poupon D, Gorwood P (2025): Detecting the comorbidity of attention deficit hyperactivity disorder (ADHD) in a population of outpatients with alcohol use disorder (AUD): The role of personality traits, age at first alcohol use and level of craving. Alcohol. 2025 Feb;122:63-70. doi: 10.1016/j.alcohol.2024.11.001. PMID: 39505078. ↥ ↥ ↥
Krause, Biermann, Krause (2002): Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung bei Alkoholikern. Nervenheilkunde 21 (2002): 156-159., zitiert nach Edel, Vollmoeller: Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung bei Erwachsenen, 2006, Seite 106 ↥
Lohit, Babu, Sharma, Rao, Sachin, Matkar (2019): Prevalence of Adult ADHD Co-morbidity in Alcohol Use Disorders in a General Hospital Setup. Indian J Psychol Med. 2019 Nov 11;41(6):523-528. doi: 10.4103/IJPSYM.IJPSYM_464_18. eCollection 2019 Nov-Dec. ↥
August, Winters, Realmuto, Fahnhorst, Botzet, Lee (2006): Prospective study of adolescent drug use among community samples of ADHD and non-ADHD participants. J Am Acad Child Adolesc Psychiatry. 2006 Jul;45(7):824-32. doi: 10.1097/01.chi.0000219831.16226.f8. PMID: 16832319. ↥
Philipsen, Heßlinger, Tebartz van Elst: AufmerksamkeitsdefizitHyperaktivitätsstörung im Erwachsenenalter – Diagnostik, Ätiologie und Therapie (ÜBERSICHTSARBEIT), Deutsches Ärzteblatt, Jg. 105, Heft 17, 25. April 2008, Seite 311 – 317, 313 , Seite 313 unter Verweis auf Rösler, Heßlinger, Philipsen (2007): ADHS im Erwachsenenalter. In: Voderholzer, Hohagen (Hrsg.): Therapie psychischer Erkrankungen – State of the Art. 2. Auflage. München: Urban & Fischer, 2007 ↥
Edel, Vollmoeller: Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung bei Erwachsenen, 2006, Seite 106 mwNw ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Biederman, Wilens, Mick, Milberger, Spencer, Faraone (1995): Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. Am J Psychiatry. 1995 Nov;152(11):1652-8. ↥
Weiss et al. 1985, Gittelman et al. 1985, zitiert nach Oehler (2009), Vortrag beim 4. ADHS-Gipfel in Hamburg, 06.-08.02.2009 ↥
Martínez-Luna, Daigre, Palma-Álvarez, Perea-Ortueta, Grau-López, Roncero, Castell-Panisello, Ramos-Quiroga (2019): Psychiatric Comorbidity and Addiction Severity Differences in Patients With ADHD Seeking Treatment for Cannabis or Cocaine Use Disorders. J Atten Disord. 2019 Sep 24:1087054719875787. doi: 10.1177/1087054719875787. ↥
Philipsen, Heßlinger, Tebartz van Elst: Aufmerksamkeitsdefizit-Hyperaktivitätsstörung im Erwachsenenalter – Diagnostik, Ätiologie und Therapie (ÜBERSICHTSARBEIT), Deutsches Ärzteblatt, Jg. 105, Heft 17, 25. April 2008, Seite 311 – 317, 313 Seite 313 ↥
Lugoboni, Zamboni, Mantovani, Cibin, Tamburin (2020): Gruppo InterSERT di Collaborazione Scientifica. Association between Adult Attention Deficit/Hyperactivity Disorder and Intravenous Misuse of Opioid and Benzodiazepine in Patients under Opioid Maintenance Treatment: A Cross-Sectional Multicentre Study. Eur Addict Res. 2020 Jan 29;1-11. doi: 10.1159/000505207. PMID: 31995807. n = 1.649 ↥
Levin, Evans, Kleber (1998): Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment. Drug Alcohol Depend. 1998 Sep 1;52(1):15-25. ↥
Jacob, Haro, Koyanagi (2018): Relationship between attention-deficit hyperactivity disorder symptoms and problem gambling: A mediation analysis of influential factors among 7,403 individuals from the UK. J Behav Addict. 2018 Sep 21:1-11. doi: 10.1556/2006.7.2018.72. n = 7403 ↥
So R, Sato Y, Hashimoto N, Furukawa TA (2023): Prevalence of suspected autism spectrum disorder and attention-deficit hyperactivity disorder in a Japanese clinical sample with gambling disorder: A cross-sectional study. PCN Rep. 2023 Aug 13;2(3):e131. doi: 10.1002/pcn5.131. PMID: 38867830; PMCID: PMC11114339. ↥ ↥
García-Marín, Campos, Cuéllar-Partida, Medland, Kollins, Rentería (2021): Large-scale genetic investigation reveals genetic liability to multiple complex traits influencing a higher risk of ADHD. Sci Rep. 2021 Nov 19;11(1):22628. doi: 10.1038/s41598-021-01517-7. PMID: 34799595. ↥ ↥ ↥
Prof. Dr. Tobias Renner, Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung Störungen des Sozialverhaltens; nicht mehr online ↥
Kessler, Adler, Barkley, Biederman, Conners, Demler, Faraone, Greenhill, Howes, Secnik, Spencer, Ustun, Walters, Zaslavsky (2006): The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006 Apr;163(4):716-23. doi: 10.1176/ajp.2006.163.4.716. PMID: 16585449; PMCID: PMC2859678. ↥
Prävalenzraten des Konsums illegaler Drogen unter deutschen Erwachsenen - ausgewählten Substanzen im Jahr 2019, Statista ↥
Luderer, Sick, Kaplan-Wickel, Reinhard, Richter, Kiefer, Weber (2020): Prevalence Estimates of ADHD in a Sample of Inpatients With Alcohol Dependence. J Atten Disord. 2020 Dec;24(14):2072-2083. doi: 10.1177/1087054717750272. PMID: 29308693. ↥
Glass, Flory, Martin, Hankin, (2011). ADHD and comorbid conduct problems among adolescents: Associations with self-esteem and substance use. ADHD Attention Deficit and Hyperactivity Disorders, 3, 29–39, zitiert nach Sören Schmidt und Franz Petermann, ADHS über die Lebensspanne – Symptome und neue diagnostische Ansätze, Zeitschrift für Psychiatrie, Psychologie und Psychotherapie, 59 (3), 2011, 227–238, Seite 229 ↥
Brook, Duan, Zhang, Cohen, Brook, (2008). The association between attention deficit hyperactivity disorder in adolescence and smoking in Adulthood. American Journal on Addictions, 17, 54 – 59., zitiert nach Sören Schmidt und Franz Petermann, ADHS über die Lebensspanne – Symptome und neue diagnostische Ansätze, Zeitschrift für Psychiatrie, Psychologie und Psychotherapie, 59 (3), 2011, 227–238, Seite 229 ↥
Slobodin, Blankers, Kapitány-Fövény, Kaye, Berger, Johnson, Demetrovics, van den Brink, van de Glind (2020): Differential Diagnosis in Patients with Substance Use Disorder and/or Attention-Deficit/Hyperactivity Disorder Using Continuous Performance Test. Eur Addict Res. 2020;26(3):151-162. doi: 10.1159/000506334. PMID: 32074617. ↥
Prof. Dr. Tobias Renner, Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung Störungen des Sozialverhaltens ↥
Kraus, Seitz, Rauschert (2020): Epidemiologischer Suchtsurvey Berlin 2018 ↥
Deutsche Hauptstelle für Suchtfragen (2019): Jahrbuch Sucht 2019, S. 106 ↥
Treur, Demontis, Smith, Sallis, Richardson, Wiers, Børglum, Verweij, Munafò (2019): Investigating causality between liability to ADHD and substance use, and liability to substance use and ADHD risk, using Mendelian randomization. Addict Biol. 2019 Nov 16:e12849. doi: 10.1111/adb.12849. ↥
Wimberley, Agerbo, Horsdal, Ottosen, Brikell, Als, Demontis, Børglum, Nordentoft, Mors, Werge, Hougaard, Bybjerg-Grauholm, Hansen, Mortensen, Thapar, Riglin, Langley, Dalsgaard (2019): Genetic liability to ADHD and substance use disorders in individuals with ADHD. Addiction. 2019 Dec 5. doi: 10.1111/add.14910. ↥
Brunklaus (2006): Vergleich von Symptomen des Hyperkinetischen Syndroms bei politoxikomanen Patienten in Suchtbehandlung und gesunden Kontrollprobanden, Dissertation, 6.2.4 ↥
Brunklaus (2006): Vergleich von Symptomen des Hyperkinetischen Syndroms bei politoxikomanen Patienten in Suchtbehandlung und gesunden Kontrollprobanden, Dissertation, 6.2.5 ↥
Brunklaus (2006): Vergleich von Symptomen des Hyperkinetischen Syndroms bei politoxikomanen Patienten in Suchtbehandlung und gesunden Kontrollprobanden, Dissertation, 6.2.6 ↥
Brunklaus (2006): Vergleich von Symptomen des Hyperkinetischen Syndroms bei politoxikomanen Patienten in Suchtbehandlung und gesunden Kontrollprobanden, Dissertation, 6.2.8 ↥ ↥
Vaziri-Harami R, Khademi M, Zolfaghari A, Vaziri-Harami S (2024): Patterns of substance use and initiation timing in adults with substance abuse: a comparison between those with and without attention deficit hyperactivity disorder. Ann Med Surg (Lond). 2024 Jun 13;86(8):4397-4401. doi: 10.1097/MS9.0000000000002272. PMID: 39118714; PMCID: PMC11305728. ↥
Hässler, Irmisch: Biochemische Störungen bei Kindern mit AD(H)S, Seite 88, in Steinhausen (Hrsg.) (2000): Hyperkinetische Störungen bei Kindern, Jugendlichen und Erwachsenen, 2. Aufl., Kohlhammer ↥
Migueis DP, Lopes MC, Casella E, Soares PV, Soster L, Spruyt K (2023): Attention deficit hyperactivity disorder and restless leg syndrome across the lifespan: A systematic review and meta-analysis. Sleep Med Rev. 2023 Feb 27;69:101770. doi: 10.1016/j.smrv.2023.101770. PMID: 36924608. METASTUDIE ↥
Oner, Dirik, Taner, Caykoylu, Anlar (2007): Association between low serum ferritin and restless legs syndrome in patients with attention deficit hyperactivity disorder. Tohoku J Exp Med. 2007 Nov;213(3):269-76. doi: 10.1620/tjem.213.269. PMID: 17984624. n = 87 ↥
Cortese, Konofal, Lecendreux, Arnulf, Mouren, Darra, Dalla Bernardina (2005): Restless legs syndrome and attention-deficit/hyperactivity disorder: a review of the literature. Sleep. 2005 Aug 1;28(8):1007-13. doi: 10.1093/sleep/28.8.1007. PMID: 16218085. REVIEW ↥ ↥
Zak, Fisher, Couvadelli, Moss, Walters (2009): Preliminary study of the prevalence of restless legs syndrome in adults with attention deficit hyperactivity disorder. Percept Mot Skills. 2009 Jun;108(3):759-63. doi: 10.2466/PMS.108.3.759-763. PMID: 19725311. n = 30 ↥
Huang, Chen, Li, Wu, Chao, Guilleminault (2004): Sleep disorders in Taiwanese children with attention deficit/hyperactivity disorder. J Sleep Res. 2004 Sep;13(3):269-77. doi: 10.1111/j.1365-2869.2004.00408.x. PMID: 15339263. n = 88 ↥
Picchietti, Underwood, Farris, Walters, Shah, Dahl, Trubnick, Bertocci, Wagner, Hening (1999): Further studies on periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder. Mov Disord. 1999 Nov;14(6):1000-7. doi: 10.1002/1531-8257(199911)14:6<1000::aid-mds1014>3.0.co;2-p. PMID: 10584676. ↥
Fulda S, Miano S. Time to rest a hypothesis? Accumulating evidence that periodic leg movements during sleep are not increased in children with attention deficit hyperactivity disorder (ADHD): results of a case-control study and a meta-analysis. Sleep. 2023 Mar 3:zsad046. doi: 10.1093/sleep/zsad046. Epub ahead of print. PMID: 36869787. METASTUDIE ↥
Didriksen, Thørner, Erikstrup, Pedersen, Paarup, Petersen, Hansen, Banasik, Nielsen, Hjalgrim, Jennum, Sørensen, Burgdorf, Ullum (2019): Self-reported restless legs syndrome and involuntary leg movements during sleep are associated with symptoms of attention deficit hyperactivity disorder. Sleep Med. 2019 Feb 11;57:115-121. doi: 10.1016/j.sleep.2019.01.039. n = 25.336 ↥
Picchietti, Allen, Walters, Davidson, Myers, Ferini-Strambi (2007): Restless legs syndrome: prevalence and impact in children and adolescents–the Peds REST study. Pediatrics. 2007 Aug;120(2):253-66. doi: 10.1542/peds.2006-2767. PMID: 17671050. ↥
Tilma, Thomsen, Ostergaard (2014): [A possible coexistence between restless legs syndrom and attention deficit hyperactivity disorder]. Ugeskr Laeger. 2014 Feb 17;176(4):V11120672. Danish. PMID: 25095868. REVIEW ↥ ↥ ↥ ↥
Konofal, Cortese, Marchand, Mouren, Arnulf, Lecendreux (2007): Impact of restless legs syndrome and iron deficiency on attention-deficit/hyperactivity disorder in children. Sleep Med. 2007 Nov;8(7-8):711-5. doi: 10.1016/j.sleep.2007.04.022. PMID: 17644481. ↥ ↥
Konofal, Lecendreux, Arnulf, Mouren (2004): Iron deficiency in children with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 2004 Dec;158(12):1113-5. doi: 10.1001/archpedi.158.12.1113. PMID: 15583094. ↥
Lahat, Heyman, Livne, Goldman, Berkovitch, Zachor (2011): Iron deficiency in children with attention deficit hyperactivity disorder. Isr Med Assoc J. 2011 Sep;13(9):530-3. PMID: 21991711. ↥
Millichap, Yee, Davidson (2006): Serum ferritin in children with attention-deficit hyperactivity disorder. Pediatr Neurol. 2006 Mar;34(3):200-3. doi: 10.1016/j.pediatrneurol.2005.09.001. PMID: 16504789. ↥
Cortese, Angriman (2014): Attention-deficit/hyperactivity disorder, iron deficiency, and obesity: is there a link? Postgrad Med. 2014 Jul;126(4):155-70. doi: 10.3810/pgm.2014.07.2793. PMID: 25141253. REVIEW ↥
Trenkwalder, Paulus (2010): Restless legs syndrome: pathophysiology, clinical presentation and management. Nat Rev Neurol. 2010 Jun;6(6):337-46. doi: 10.1038/nrneurol.2010.55. PMID: 20531433. REVIEW ↥
Picchietti MA, Picchietti DL. Advances in pediatric restless legs syndrome: Iron, genetics, diagnosis and treatment. Sleep Med. 2010 Aug;11(7):643-51. doi: 10.1016/j.sleep.2009.11.014. PMID: 20620105. REVIEW ↥
Simakajornboon, Kheirandish-Gozal, Gozal (2009): Diagnosis and management of restless legs syndrome in children. Sleep Med Rev. 2009 Apr;13(2):149-56. doi: 10.1016/j.smrv.2008.12.002. PMID: 19186083; PMCID: PMC2911577. REVIEW ↥
Connor, Boyer, Menzies, Dellinger, Allen, Ondo, Earley (2003): Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology. 2003 Aug 12;61(3):304-9. doi: 10.1212/01.wnl.0000078887.16593.12. PMID: 12913188. ↥
Allen, Earley (2007): The role of iron in restless legs syndrome. Mov Disord. 2007;22 Suppl 18:S440-8. doi: 10.1002/mds.21607. Erratum in: Mov Disord. 2008 Jun;23(8):1200-2. PMID: 17566122. REVIEW ↥
Konofal, Lecendreux, Deron, Marchand, Cortese, Zaïm, Mouren, Arnulf (2008): Effects of iron supplementation on attention deficit hyperactivity disorder in children. Pediatr Neurol. 2008 Jan;38(1):20-6. doi: 10.1016/j.pediatrneurol.2007.08.014. PMID: 18054688. n = 23 ↥
Ferré, Guitart, Quiroz, Rea, García-Malo, Garcia-Borreguero, Allen, Earley (2021): Akathisia and Restless Legs Syndrome: Solving the Dopaminergic Paradox. Sleep Med Clin. 2021 Jun;16(2):249-267. doi: 10.1016/j.jsmc.2021.02.012. PMID: 33985651. ↥
P LMB, E SSA, Castro-Villacañas, Garcia-Borreguero (2021): Restless Legs Syndrome: Challenges to Treatment. Sleep Med Clin. 2021 Jun;16(2):269-277. doi: 10.1016/j.jsmc.2021.02.003. PMID: 33985652. ↥
England, Picchietti, Couvadelli, Fisher, Siddiqui, Wagner, Hening, Lewin, Winnie, Cohen, Walters (2011): L-Dopa improves Restless Legs Syndrome and periodic limb movements in sleep but not Attention-Deficit-Hyperactivity Disorder in a double-blind trial in children. Sleep Med. 2011 May;12(5):471-7. doi: 10.1016/j.sleep.2011.01.008. PMID: 21463967; PMCID: PMC3094572. ↥
Konofal, Arnulf, Lecendreux, Mouren (2005): Ropinirole in a child with attention-deficit hyperactivity disorder and restless legs syndrome. Pediatr Neurol. 2005 May;32(5):350-1. doi: 10.1016/j.pediatrneurol.2004.11.007. PMID: 15866437. ↥
Broughton T, Lambert E, Wertz J, Agnew-Blais J (2025): Increased risk of provisional premenstrual dysphoric disorder (PMDD) among females with attention-deficit hyperactivity disorder (ADHD): cross-sectional survey study. Br J Psychiatry. 2025 Jun;226(6):410-417. doi: 10.1192/bjp.2025.104. PMID: 40528384; PMCID: PMC7617793. n = 715 ↥
Joshi, Wilens (2022): Pharmacotherapy of Attention-Deficit/Hyperactivity Disorder in Individuals with Autism Spectrum Disorder. Child Adolesc Psychiatr Clin N Am. 2022 Jul;31(3):449-468. doi: 10.1016/j.chc.2022.03.012. PMID: 35697395. REVIEW ↥ ↥
Jiang Z, Li G, Zeng S, Li J, Li Y, Lin J, Fan Q (2024): Causal Relationship between Attention-Deficit Hyperactivity Disorder and Autism Spectrum Disorder: A Two-Sample Mendelian Randomization. Br J Hosp Med (Lond). 2024 Dec 30;85(12):1-16. doi: 10.12968/hmed.2024.0588. Epub 2024 Dec 27. PMID: 39831504. ↥ ↥
Castellanos, Tannock (2002): Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci. 2002 Aug;3(8):617-28.; PMID: 12154363 DOI: 10.1038/nrn896, S. 619 ↥ ↥
Lee J, Lee SI (2023):Unrecognized comorbid autism spectrum disorder in children initially diagnosed with only attention deficit hyperactivity disorder. Asian J Psychiatr. 2023 Jul;85:103629. doi: 10.1016/j.ajp.2023.103629. PMID: 37243986. ↥
Mohammadi, Ahmadi, Khaleghi, Zarafshan, Mostafavi, Kamali, Rahgozar, Ahmadi, Hooshyari, Alavi, Shakiba, Salmanian, Molavi, Sarraf, Hojjat, Mohammadzadeh, Amiri, Arman, Ghanizadeh (2019): Prevalence of Autism and its Comorbidities and the Relationship with Maternal Psychopathology: A National Population-Based Study. Arch Iran Med. 2019 Oct 1;22(10):546-553. ↥
Lundström, Mårland, Kuja-Halkola, Anckarsäter, Lichtenstein, Gillberg, Nilsson (2019): Assessing autism in females: The importance of a sex-specific comparison. Psychiatry Res. 2019 Sep 13:112566. doi: 10.1016/j.psychres.2019.112566. n = 30.392 ↥
Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators; Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders–Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ. 2012 Mar 30;61(3):1-19. PMID: 22456193. ↥
Panagiotidi, Overton, Stafford (2017): Co-Occurrence of ASD and ADHD Traits in an Adult Population.J Atten Disord. 2017 Aug 1:1087054717720720. doi: 10.1177/1087054717720720; n = 334 ↥ ↥
Hara (2019): [Chronic Activation of the Dopaminergic Neuronal Pathway Improves Behavioral Abnormalities in the Prenatal Valproic Acid Exposure Mouse Model of Autism Spectrum Disorder]. [Article in Japanese] Yakugaku Zasshi. 2019;139(11):1391-1396. doi: 10.1248/yakushi.19-00131. ↥
Kaye AD, Allen KE, Smith Iii VS, Tong VT, Mire VE, Nguyen H, Lee Z, Kouri M, Jean Baptiste C, Mosieri CN, Kaye AM, Varrassi G, Shekoohi S (2024): Emerging Treatments and Therapies for Autism Spectrum Disorder: A Narrative Review. Cureus. 2024 Jul 2;16(7):e63671. doi: 10.7759/cureus.63671. PMID: 39092332; PMCID: PMC11293483. REVIEW ↥
Rothenberger, Lauth, Ramacher-Faasen, Braun, Bock, von Aster, von Aster, von Aster in Lernen und Lernstörungen (2014), 3, pp. 185-202. DOI: 10.1024/2235-0977/a000071: Kommentare zu Romanos & Jans (2014). ADHS – an der Nahtstelle von Medizin und Pädagogik. Lernen und Lernstörungen, 3, 117 – 132; DOI: http://dx.doi.org/10.1024/2235-0977/a000071 ↥ ↥ ↥
Büber, Başay, Şenol (2020): The prevalence and comorbidity rates of specific learning disorder among primary school children in Turkey. Nord J Psychiatry. 2020 Aug;74(6):453-460. doi: 10.1080/08039488.2020.1740782. PMID: 32186228. n = 1.041 ↥
Rothenberger, Lauth, Ramacher-Faasen, Braun, Bock, von Aster, von Aster, von Aster in Lernen und Lernstörungen (2014), 3, pp. 185-202. DOI: 10.1024/2235-0977/a000071: ↥
Kommentare zu Romanos & Jans (2014). ADHS-HI – an der Nahtstelle von Medizin und Pädagogik. Lernen und Lernstörungen, 3, 117 – 132; DOI: http://dx.doi.org/10.1024/2235-0977/a000071 ↥
Ciulkinyte A, Mountford HS, Fontanillas P; 23andMe Research Team; Bates TC, Martin NG, Fisher SE, Luciano M (2024): Genetic neurodevelopmental clustering and dyslexia. Mol Psychiatry. 2024 Jul 15. doi: 10.1038/s41380-024-02649-8. PMID: 39009701. ↥
van Bergen E, de Zeeuw EL, Hart SA, Boomsma DI, de Geus EJC, Kan KJ (2025): *Co-Occurrence and Causality Among ADHD, Dyslexia, and Dyscalculia. Psychol Sci. 2025 Mar;36(3):204-217. doi: 10.1177/09567976241293999. PMID: 40098496. ↥ ↥ ↥
McGrath, Stoodley (2019): Are there shared neural correlates between dyslexia and ADHD? A meta-analysis of voxel-based morphometry studies. J Neurodev Disord. 2019 Nov 21;11(1):31. doi: 10.1186/s11689-019-9287-8. ↥
Sarisuta P, Chunsuwan I, Hansakunachai T, Sritipsukho P. Attention-deficit/hyperactive-impulsive disorder symptoms among grade 1 students with reading disorder in Thailand. Clin Exp Pediatr. 2023 Nov;66(11):485-492. doi: 10.3345/cep.2023.00773. PMID: 37873565; PMCID: PMC10626022. n = 703 ↥
Horowitz-Kraus, Hershey, Kay, DiFrancesco (2019): Differential effect of reading training on functional connectivity in children with reading difficulties with and without ADHD comorbidity. J Neurolinguistics. 2019 Feb;49:93-108. doi: 10.1016/j.jneuroling.2018.09.002. ↥
Schuhmacher (2016): Fehler muss man sehen! Visuelle Funktions- und Informationsverarbeitungsstörungen bei Schulkindern. Vortrag, Youtube ↥
Edel, Vollmoeller: Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung bei Erwachsenen, 2006, Seite 40 ↥ ↥
Daucourt, Erbeli, Little, Haughbrook, Hart (2020): A Meta-Analytical Review of the Genetic and Environmental Correlations between Reading and Attention-Deficit Hyperactivity Disorder Symptoms and Reading and Math. Sci Stud Read. 2020;24(1):23-56. doi: 10.1080/10888438.2019.1631827. PMID: 32189961; PMCID: PMC7079676. METASTUDIE ↥
Kanevski M, Booth JN, Stewart TM, Rhodes SM (2024): Cognitive heterogeneity in Attention Deficit Hyperactivity Disorder: Implications for maths. Br J Dev Psychol. 2024 Nov;42(4):596-621. doi: 10.1111/bjdp.12517. PMID: 39166844. ↥
Gaye F, Harmon SL, Cole AM, Marsh CL, Liu Q, Mcintosh A, Kofler MJ (2025): Examining the roles of working memory and trait anxiety on math achievement in children with ADHD. Neuropsychology. 2025 Mar;39(3):259-274. doi: 10.1037/neu0000994. PMID: 40063373; PMCID: PMC11926614. ↥
Lauth: ADHS bei Erwachsenen: Diagnostik und Behandlung von Aufmerksamkeits-/ Hyperaktivitätsstörungen, Seite 97 ↥ ↥
Varheenmaa M, Lehto SM, Rizzo P, Steinhausen HC, Drechsler R, Brem AK (2024): Facial emotion recognition in children with attention deficit hyperactivity disorder. Nord J Psychiatry. 2024 Oct;78(7):634-643. doi: 10.1080/08039488.2024.2403589. PMID: 39294899; PMCID: PMC11458127. ↥
Mansour S, Mwafi N, Al-Tawarah N, Masoud B, Ab{u-Tapanjeh H, Alkhawaldeh I, Qawaqzeh M, Amro R, Mazahreh S (2023): PREVALENCE OF LEFT/RIGHT CONFUSION AMONG MEDICAL STUDENTS IN MUTAH UNIVERSITY- JORDAN. Georgian Med News. 2023 Nov;(344):85-89. PMID: 38236104. ↥
Meier, Pavlova, Dalsgaard, Nordentoft, Mors, Mortensen, Uher (2018): Attention-deficit hyperactivity disorder and anxiety disorders as precursors of bipolar disorder onset in adulthood. Br J Psychiatry. 2018 Sep;213(3):555-560. doi: 10.1192/bjp.2018.111. ↥
Fahrendorff AM, Pagsberg AK, Kessing LV, Maigaard K (2023): Psychiatric comorbidity in patients with pediatric bipolar disorder - A systematic review. Acta Psychiatr Scand. 2023 Mar 20. doi: 10.1111/acps.13548. PMID: 36941106. ↥
Mishra VC, Solanki G, Singh D, Goyal MK (2023): Prevalence and clinical correlates of co-morbid attention deficit hyperactivity disorder in euthymic adults with bipolar disorder: A cross-sectional study. Indian J Psychiatry. 2023 Nov;65(11):1129-1136. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_647_23. PMID: 38249150; PMCID: PMC10795658. n = 110 ↥
Pinna, Visioli, Rago, Manchia, Tondo, Baldessarini (2018): Attention deficit-hyperactivity disorder in adult bipolar disorder patients. J Affect Disord. 2018 Sep 17;243:391-396. doi: 10.1016/j.jad.2018.09.038. ↥
Hossain, Mainali, Bhimanadham, Imran, Ahmad, Patel (2019): Medical and Psychiatric Comorbidities in Bipolar Disorder: Insights from National Inpatient Population-based Study. Cureus. 2019 Sep 12;11(9):e5636. doi: 10.7759/cureus.5636. ↥
Grigoroiu-Serbanescu, Giaroli, Thygesen, Shenyan, Bigdeli, Bass, Diaconu, Neagu, Forstner, Degenhardt, Herms, Nöthen, McQuillin (2019): Predictive power of the ADHD GWAS 2019 polygenic risk scores in independent samples of bipolar patients with childhood ADHD. J Affect Disord. 2019 Nov 23. pii: S0165-0327(19)32310-9. doi: 10.1016/j.jad.2019.11.109. ↥
O’Connell, Shadrin, Bahrami, Smeland, Bettella, Frei, Krull, Askeland, Walters, Davíðsdóttir, Haraldsdóttir, Guðmundsson, Stefánsson, Fan, Steen, Reichborn-Kjennerud, Dale, Stefánsson, Djurovic, Andreassen (2019): Identification of genetic overlap and novel risk loci for attention-deficit/hyperactivity disorder and bipolar disorder. Mol Psychiatry. 2019 Dec 2. doi: 10.1038/s41380-019-0613-z. n = 105.000 ↥
Reinblatt, Mahone, Tanofsky-Kraff, Lee-Winn, Yenokyan, Leoutsakos, Moran, Guarda, Riddle (2015): Pediatric loss of control eating syndrome: Association with attention-deficit/hyperactivity disorder and impulsivity. Int J Eat Disord. 2015 Sep;48(6):580-8. doi: 10.1002/eat.22404. ↥
Mohammadi, Mostafavi, Hooshyari, Khaleghi, Ahmadi, Molavi, Armani Kian, Safavi, Delpisheh, Talepasand, Hojjat, Pourdehghan, Ostovar, Hosseini, Mohammadzadeh, Salmanian, Alavi, Ahmadi, Zarafshan (2019): Prevalence, correlates and comorbidities of feeding and eating disorders in a nationally representative sample of Iranian children and adolescents. Int J Eat Disord. 2019 Nov 19. doi: 10.1002/eat.23197. n = 27.111 ↥
Schiros A, Antshel KM (2022): The relationship between anorexia nervosa and bulimia nervosa, attention deficit/hyperactivity disorder, and suicidality in college students. Eur Eat Disord Rev. 2022 Dec 5. doi: 10.1002/erv.2962. PMID: 36468533. n = 342.432 ↥
Namimi-Halevi C, Dor C, Stark AH, Dichtiar R, Bromberg M, Sinai T (2023): Attention-deficit hyperactivity disorder is associated with disordered eating in adolescents. Pediatr Res. 2023 Dec 4. doi: 10.1038/s41390-023-02925-3. PMID: 38049648. ↥
Adamis D, Kasianenko D, Usman M, Saleem F, Wrigley M, Gavin B, McNicholas F (2023): Prevalence of Personality Disorders in Adults With Attention Deficit Hyperactivity Disorder (ADHD). J Atten Disord. 2023 Mar 16:10870547231161531. doi: 10.1177/10870547231161531. PMID: 36927130. n = 147 ↥
Mannuzza, Klein, Bessler, Malloy, LaPadula (1993): Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry. 1993 Jul;50(7):565-76. doi: 10.1001/archpsyc.1993.01820190067007. PMID: 8317950. n = 103 ↥
Nach ADHS-Netzwerkstudie “Persönlichkeitsstörungen”, n = 156, zitiert nach NICOLAY (2009); IPSM-adhs Grundlagen, Teil 3 ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Buitelaar, Posthumus, Bijlenga, Buitelaar (2019): The Impact of ADHD Treatment on Intimate Partner Violence in a Forensic Psychiatry Setting. J Atten Disord. 2019 Oct 16:1087054719879502. doi: 10.1177/1087054719879502. ↥
Matthies S, van Elst LT, Feige B, Fischer D, Scheel C, Krogmann E, Perlov E, Ebert D, Philipsen A (2011): Severity of childhood attention-deficit hyperactivity disorder–a risk factor for personality disorders in adult life? J Pers Disord. 2011 Feb;25(1):101-14. doi: 10.1521/pedi.2011.25.1.101. PMID: 21309626. ↥
Kuja-Halkola R, Lind Juto K, Skoglund C, Rück C, Mataix-Cols D, Pérez-Vigil A, Larsson J, Hellner C, Långström N, Petrovic P, Lichtenstein P, Larsson H (2021): Do borderline personality disorder and attention-deficit/hyperactivity disorder co-aggregate in families? A population-based study of 2 million Swedes. Mol Psychiatry. 2021 Jan;26(1):341-349. doi: 10.1038/s41380-018-0248-5. PMID: 30323291; PMCID: PMC7815504. ↥ ↥
Jacob CP, Romanos J, Dempfle A, Heine M, Windemuth-Kieselbach C, Kruse A, Reif A, Walitza S, Romanos M, Strobel A, Brocke B, Schäfer H, Schmidtke A, Böning J, Lesch KP (2007): Co-morbidity of adult attention-deficit/hyperactivity disorder with focus on personality traits and related disorders in a tertiary referral center. Eur Arch Psychiatry Clin Neurosci. 2007 Sep;257(6):309-17. doi: 10.1007/s00406-007-0722-6. PMID: 17401730. ↥
Ditrich I, Philipsen A, Matthies S (2021): Borderline personality disorder (BPD) and attention deficit hyperactivity disorder (ADHD) revisited - a review-update on common grounds and subtle distinctions. Borderline Personal Disord Emot Dysregul. 2021 Jul 6;8(1):22. doi: 10.1186/s40479-021-00162-w. PMID: 34229766; PMCID: PMC8261991. REVIEW ↥
Weibel S, Nicastro R, Prada P, Cole P, Rüfenacht E, Pham E, Dayer A, Perroud N (2018): Screening for attention-deficit/hyperactivity disorder in borderline personality disorder. J Affect Disord. 2018 Jan 15;226:85-91. doi: 10.1016/j.jad.2017.09.027. PMID: 28964997. ↥
Philipsen A, Limberger MF, Lieb K, Feige B, Kleindienst N, Ebner-Priemer U, Barth J, Schmahl C, Bohus M (2008): Attention-deficit hyperactivity disorder as a potentially aggravating factor in borderline personality disorder. Br J Psychiatry. 2008 Feb;192(2):118-23. doi: 10.1192/bjp.bp.107.035782. PMID: 18245028. ↥
Fossati A, Novella L, Donati D, Donini M, Maffei C (2002): History of childhood attention deficit/hyperactivity disorder symptoms and borderline personality disorder: a controlled study. Compr Psychiatry. 2002 Sep-Oct;43(5):369-77. doi: 10.1053/comp.2002.34634. PMID: 12216012. ↥
Vuksanovic (2013): Die Aktivität der Hpothalamus-Hypophysen-Nebennierenrinden-Achse bei Aufmerksamkeits-Defizit und Hyperaktivitäts-Störung, Dissertation, Seite 102, 114 ↥
Wang S, Yao B, Zhang H, Xia L, Yu S, Peng X, Xiang D, Liu Z (2023): Comorbidity of epilepsy and attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. J Neurol. 2023 Jun 16. doi: 10.1007/s00415-023-11794-z. PMID: 37326829. ↥
Fu J, Li Q, Zhang G, Yang Z, Qin J (2025): Neuropsychiatric disorders in Chinese pediatric tuberous sclerosis complex patients associated with drug-resistant epilepsy: A TAND checklist-based survey. Epilepsy Behav Rep. 2025 Apr 3;30:100765. doi: 10.1016/j.ebr.2025.100765. PMID: 40242083; PMCID: PMC12001132. ↥
Ashjazadeh, Sahraeian, Sabzgolin, Asadi-Pooya (2019): Attention-deficit hyperactivity disorder in adults with epilepsy. Epilepsy Behav. 2019 Nov 4;101(Pt A):106543. doi: 10.1016/j.yebeh.2019.106543. n = 200 ↥
Ahlqvist VH, Dardani C, Madley-Dowd P, Forbes H, Rast J, Zhong C, Gardner RM, Dalman C, Lyall K, Newschaffer C, Tomson T, Lundberg M, Berglind D, Davies NM, Lee BK, Magnusson C, Rai D (2024): Psychiatric comorbidities in epilepsy: population co-occurrence, genetic correlations and causal effects. Gen Psychiatr. 2024 Jan 30;37(1):e101201. doi: 10.1136/gpsych-2023-101201. PMID: 39228867; PMCID: PMC11369844. n = 7.628.495 ↥ ↥
Dunbar, Lee, Maheshwari (2019): High Yield of Screening for ADHD in the Epilepsy Monitoring Unit. J Atten Disord. 2019 Nov 9:1087054719886359. doi: 10.1177/1087054719886359. ↥
Uliel-Sibony S, Chernuha V, Latzer IT, Leitner Y (2023): Epilepsy and attention-deficit/hyperactivity disorder in children and adolescents: An overview of etiology, prevalence, and treatment. Front Hum Neurosci. 2023 Apr 11;17:1021605. doi: 10.3389/fnhum.2023.1021605. PMID: 37113319; PMCID: PMC10126237. ↥
Nourredine M, Gering A, Fourneret P, Rolland B, Falissard B, Cucherat M, Geoffray MM, Jurek L (2021): Association of Attention-Deficit/Hyperactivity Disorder in Childhood and Adolescence With the Risk of Subsequent Psychotic Disorder: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2021 May 1;78(5):519-529. doi: 10.1001/jamapsychiatry.2020.4799. PMID: 33625499; PMCID: PMC7905700. METASTUDY ↥
Schulze JB, Simnacher F, Müller TJ, Kirchebner J, Quatela F, Mikutta C, Euler S, von Känel R, Günther MP (2025): ADHD and schizophrenia: Mere prodromal variant or homogeneous subgroup? Schizophr Res Cogn. 2025 Jun 18;42:100374. doi: 10.1016/j.scog.2025.100374. PMID: 40605957; PMCID: PMC12214124. ↥
Jeon SM, Lee DY, Cha S, Kwon JW (2023): Psychiatric Comorbidities and Schizophrenia in Youths With Attention-Deficit/Hyperactivity Disorder. JAMA Netw Open. 2023 Nov 1;6(11):e2345793. doi: 10.1001/jamanetworkopen.2023.45793. PMID: 38032637; PMCID: PMC10690465. n = 211.705 ↥
Arican I, Bass N, Neelam K, Wolfe K, McQuillin A, Giaroli G (2019): Prevalence of attention deficit hyperactivity disorder symptoms in patients with schizophrenia. Acta Psychiatr Scand. 2019 Jan;139(1):89-96. doi: 10.1111/acps.12948. PMID: 30105761; PMCID: PMC6412852. METASTUDY ↥ ↥
Arican I, Bass N, Neelam K, Wolfe K, McQuillin A, Giaroli G (2019): Prevalence of attention deficit hyperactivity disorder symptoms in patients with schizophrenia. Acta Psychiatr Scand. 2019 Jan;139(1):89-96. doi: 10.1111/acps.12948. PMID: 30105761; PMCID: PMC6412852. n = 126 ↥ ↥
Huang, Cheng, Tsai, Bai, Li, Lin, Su, Chen, Chen (2020): Familial coaggregation of major psychiatric disorders among first-degree relatives of patients with obsessive-compulsive disorder: a nationwide study. Psychol Med. 2020 Jan 7:1-8. doi: 10.1017/S0033291719003696. n = 89.500 ↥
Magdi HM, Abousoliman AD, Lbrahim AM, Elsehrawy MG, El-Gazar HE, Zoromba MA (2025): Attention-deficit/hyperactivity disorder and post-traumatic stress disorder adult comorbidity: a systematic review. Syst Rev. 2025 Feb 14;14(1):41. doi: 10.1186/s13643-025-02774-7. PMID: 39953536; PMCID: PMC11829347. REVIEW ↥
Wilson J, Fida D, Maurer R, Wiley A, Rajasekera T, Spagnolo P (2025): Sex Differences in the Comorbidity between Attention Deficit-Hyperactivity Disorder and Posttraumatic Stress Disorder: A Systematic Literature Review and Meta-Analysis. medRxiv [Preprint]. 2025 Jan 10:2025.01.10.25320323. doi: 10.1101/2025.01.10.25320323. Update in: Gen Hosp Psychiatry. 2025 Apr 12;95:32-39. doi: 10.1016/j.genhosppsych.2025.04.003. PMID: 39830260; PMCID: PMC11741499. METASTUDY ↥
Knight AR, Kim S, Currao A, Lebas A, Nowak MK, Milberg WP, Fortier CB (2025): Assessing Attention-Deficit/Hyperactivity Disorder in Post-9/11 Veterans: Prevalence, Measurement Correspondence, and Comorbidity With Posttraumatic Stress Disorder. Mil Med. 2025 Apr 23;190(5-6):e1106-e1113. doi: 10.1093/milmed/usae539. PMID: 39607449; PMCID: PMC12016034. ↥ ↥
ADHS Deutschland Selbsthilfe Aachen. Abgerufen am 26.01.2024 ↥
Rapanelli M, Frick L, Pogorelov V, Ohtsu H, Bito H, Pittenger C (2017): Histamine H3R receptor activation in the dorsal striatum triggers stereotypies in a mouse model of tic disorders. Transl Psychiatry. 2017 Jan 24;7(1):e1013. doi: 10.1038/tp.2016.290. PMID: 28117842; PMCID: PMC5545743. ↥
Sawitzky-Rose (2011): Assoziation von ADHS und Übergewicht bei Kindern und Jugendlichen in Deutschland: Ergebnisse der BELLA-Studie, Dissertation ↥
Barkley, Murphy (1998): ADHD: A Clinical Workbook; Milwaukee Young Adult Outcome Study, zitiert nach Oehler (2009), Vortrag beim 4. ADHS-Gipfel in Hamburg, 06.-08.02.2009 ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Skoglund, Kopp Kallner, Skalkidou, Wikström, Lundin, Hesselman, Wikman, Sundström Poromaa (2019): Association of Attention-Deficit/Hyperactivity Disorder With Teenage Birth Among Women and Girls in Sweden. JAMA Netw Open. 2019 Oct 2;2(10):e1912463. doi: 10.1001/jamanetworkopen.2019.12463. n = 384.103 ↥
Kartal E, Scott J, Morein-Zamir S (2025): Attitudes to possessions in emerging adults: Predictors of hoarding behaviours and beliefs. Br J Clin Psychol. 2025 Jul 1. doi: 10.1111/bjc.70003. PMID: 40590164. ↥
Kuwano, Nakao, Yonemoto, Yamada, Murayama, Okada, Honda, Ikari, Tomiyama, Hasuzawa, Kanba (2020): Clinical characteristics of hoarding disorder in Japanese patients. Heliyon. 2020 Mar 6;6(3):e03527. doi: 10.1016/j.heliyon.2020.e03527. PMID: 32181397; PMCID: PMC7063155. n = 71 ↥
Tsai, Chang, Chen, Jeng, Yang, Wu (2020): Associations Between Psychiatric Disorders and Enuresis in Taiwanese Children: A National Population-Based Study. Clin Epidemiol. 2020 Feb 18;12:163-171. doi: 10.2147/CLEP.S230537. PMID: 32110107; PMCID: PMC7035896. ↥
Septier, Stordeur, Zhang, Delorme, Cortese (2019): Association between suicidal spectrum behaviors and Attention-Deficit/Hyperactivity Disorder: A systematic review and meta-analysis. Neurosci Biobehav Rev. 2019 Aug;103:109-118. doi: 10.1016/j.neubiorev.2019.05.022. ↥
Levy, Kronenberg, Crosbie, Schachar (2020): Attention-deficit/hyperactivity disorder (ADHD) symptoms and suicidality in children: The mediating role of depression, irritability and anxiety symptoms. J Affect Disord. 2020 Mar 15;265:200-206. doi: 10.1016/j.jad.2020.01.022. PMID: 32090742. n = 1.517 ↥
Yılmaz, Tamam (2018): Attention-deficit hyperactivity disorder and impulsivity in female patients with fibromyalgia. Neuropsychiatr Dis Treat. 2018 Jul 24;14:1883-1889. doi: 10.2147/NDT.S159312. eCollection 2018. n = 132 ↥
Ghanizadeh A (2008): Association of nail biting and psychiatric disorders in children and their parents in a psychiatrically referred sample of children. Child Adolesc Psychiatry Ment Health. 2008 Jun 2;2(1):13. doi: 10.1186/1753-2000-2-13. PMID: 18513452; PMCID: PMC2435519. n = 450 ↥
Chen, Pan, Huang, Hsu, Bai, Su, Li, Tsai, Cheng, Chen (2019): Coaggregation of Major Psychiatric Disorders in First-Degree Relatives of Individuals With Attention-Deficit/Hyperactivity Disorder: A Nationwide Population-Based Study. J Clin Psychiatry. 2019 Apr 30;80(3). pii: 18m12371. doi: 10.4088/JCP.18m12371. ↥
Spaull RVV, Kurian MA (2017): SLC6A3-Related Dopamine Transporter Deficiency Syndrome. 2017 Jul 27 [updated 2023 Sep 28]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 28749637. REVIEW ↥ ↥ ↥ ↥ ↥
Walsh B, Tichenor SE, Gerwin KL (2025): The Significance of a Higher Prevalence of ADHD and ADHD Symptoms in Children Who Stutter. J Speech Lang Hear Res. 2025 Jun 5;68(6):2741-2758. doi: 10.1044/2025_JSLHR-24-00668. PMID: 40366906; PMCID: PMC12173216. n = 204 ↥